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ABSTRACT
The protein lysate array is an emerging technology for quantifying the pro-
tein concentration ratios in multiple biological samples. It is gaining pop-
ularity, and has the potential to answer questions about post-translational
modifications and protein pathway relationships.
Statistical inference for a parametric quantification procedure has been
inadequately addressed in the literature, mainly due to two challenges: the
increasing dimension of the parameter space and the need to account for
dependence in the data. Each chapter of this thesis addresses one of these
issues.
In Chapter 1, an introduction to the protein lysate array quantification is
presented, followed by the motivations and goals for this thesis work.
In Chapter 2, we develop a multi-step procedure for the Sigmoidal models,
ensuring consistent estimation of the concentration level with full asymptotic
efficiency. The results obtained in this chapter justify inferential procedures
based on large-sample approximations. Simulation studies and real data
analysis are used to illustrate the performance of the proposed method in
finite-samples. The multi-step procedure is simpler in both theory and com-
putation than the single-step least squares method that has been used in
current practice.
In Chapter 3, we introduce a new model to account for the dependence
structure of the errors by a nonlinear mixed effects model. We consider a
method to approximate the maximum likelihood estimator of all the param-
eters. Using the simulation studies on various error structures, we show that
for data with non-i.i.d. errors the proposed method leads to more accurate
estimates and better confidence intervals than the existing single-step least
squares method.
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CHAPTER 1
INTRODUCTION
1.1 Overview
This dissertation concerns the statistical modeling of the protein lysate array
data. The protein array quantification poses two challenges: the increasing
dimension of the parameter space and the need to account for dependence
in the data. Each chapter of this thesis addresses one of these issues. An
introduction to the protein lysate array quantification along with the ex-
perimental setup for the array is presented in this chapter, followed by the
motivations and goals for this thesis work.
1.2 Protein Lysate Arrays
It is known that the study of cells at the protein level is much more com-
plex than at the genome level. However, the genomic studies alone cannot
explain protein structures and do not provide insight into post-translational
modifications, such as phosphorylation, acetylation and ubiquitination. A
comprehensive study of both genes and proteins is necessary to understand
the cellular basis of disease onset and progression ( [1], [2], [3], [4], [5]). A
major goal of proteomics is to identify protein changes associated with the
development of diseases such as cancer. The identified proteins are potential
biomarkers for the disease. Protein arrays are gaining popularity, and have
the potential to answer questions about post-translational modifications and
protein pathway relationships.
The protein microarray formats are mainly divided into two types: forward-
phase array (FPA) and reverse-phase array (RPA). In the forward-phase
array, various antibodies are robotically spotted on the slides and each slide
is incubated with a sample. With this format, we can perform the simul-
taneous measurement of multiple proteins across a single sample ( [6], [7]).
The reverse-phase array has the opposite configuration. Multiple samples
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are robotically spotted on the slides and each slide is incubated with an
antibody that is specific for the protein of interest. As a result, the reverse-
phase array, also called the protein lysate array, measures the levels of a
common protein across multiple samples ( [8], [9]). This thesis focuses on
the second type, the protein lysate array, and aims to measure the relative
level of a common protein in several samples .
In the protein lysate array, each sample that is a solution containing the
target protein is serially diluted by a certain factor several times. Suppose
that there are s samples assessed and each sample is 2-fold serially diluted
t times. Let ci be the protein concentration of the ith sample. Then a dilu-
tion series, ci, ci/2, ci/22, ..., ci/2(t−1) is obtained from the ith sample. Each
dilution is spotted on a nitrocellulose-coated slide in r replicates and probed
with an antibody that recognizes the target protein. Then srt spots yield
gray-level intensities with higher intensity reflecting a higher concentration
level of the protein. Note that the dilution and the replicates give rt in-
tensities for each sample allowing for a more accurate measurement than
with individual spot intensity. Figure 1.1 illustrates the protein lysate array
with s = 96 biological samples, r = 3 replicates, and t = 6 dilution levels.
This figure is taken from [10]. Panel (a) is the image of the protein lysate
array slide for the 96 samples. Panels (b) and (c) are the magnifications
corresponding to eight samples and two samples, respectively. Each sam-
ple has 18 spots with 3 replicates and 6 dilution levels. The details on the
experimental setup for the protein lysate array can be found in [10].
The gray-level on each spot has a positive relationship with the protein
concentration level that depends on the dilutions and we may assume the
following model,
yijl = g(ci/2l) + ²ijl,
where i = 1, 2, ..., s, j = 1, 2, ..., r, l = 0, 1, ..., (t − 1), g is a monotonically
increasing function, yijl is the gray-intensity level at the lth dilution of the
jth replicate for the ith sample, ci is the protein concentration level of the
ith sample and ²ijl is an error term. The function g may be assumed to have
either a parametric form or a nonparametric form. The typical parametric
model, called the Sigmoidal model, takes the form:
yijl = β1 +
β2
1 + e−β3(xi−l)
+ ²ijl, (1.1)
where β1, β2, β3 > 0, yijl is the gray-intensity level, xi is the logarithm of the
protein concentration level with base 2
(
xi = log2(ci) or xi−l = log2(ci/2l)
)
and ²ijl is an error term with E(²ijl) = 0 and var(²ijl) = σ2. We notice
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Figure 1.1: Protein lysate array design. Source: [10]. a) Layout of the
protein lysate array with s = 96 biological samples, r = 3 replicates, and
t = 6 dilution levels. b) Magnification corresponding to eight samples. c)
Magnification corresponding to two samples.
that β1 = limxi→−∞E(yijl) and β1 + β2 = limxi→∞E(yijl). Therefore, we
have rough interpretations for the parameters: β1 is the lowest intensity
level without noise, and β2 is the increment from the lowest intensity level
to the highest intensity level (representing the saturation of intensity). This
model looks like a general nonlinear regression model where yijl is a depen-
dent variable and xi is an explanatory variable. However, unlike a usual
regression model, we do not observe xi, but we need to estimate it. Un-
der the model (1.1), our goal is to estimate the common curve parameters,
β1, β2, and β3, and more importantly, the logarithm of the protein concen-
tration, xi, even though our final interest is the difference in the logarithms
of the protein concentrations, xi−x∗i , that is equivalent to log2(ci/c∗i ) where
i, i∗ = 1, 2, ..., s, i 6= i∗.
In reality, the number of replicates, r, and the number of dilution levels,
t, are limited by time and cost constraints as compared with the number
of biological samples, s, particularly when we are interested in measuring
the protein concentration levels of a large number of biological samples.
A sensible large sample framework is to consider asymptotics as both n
(= rt) and s increase, which leads to a problem where the number of un-
known parameters grows with the available data points. In this case, the
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parameter estimators, such as the maximum likelihood estimator, require a
non-standard asymptotic analysis ( [11]).
Most prior work on protein array quantification is based on the assumption
that the errors are independent. However, when we examine the residuals
obtained under the i.i.d. error assumption, this assumption appears very
questionable. The nature of the experiment warrants the existence of corre-
lation, too. The repeated measurements of each biological sample are likely
to be correlated. Also the measurements within dilution series come from
the same replicate of the same biological sample, and are thereby likely to
have correlation.
1.3 Prior Work on Protein Lysate Array Quantification
The protein lysate array is a relatively new technology for measuring the
protein concentration ratios in a large number of biological samples, and a
limited amount of statistical literature on this topic is available.
One approach for measuring the protein concentration ratios is introduced
in [12], where separate estimation for each biological sample is employed.
They propose two methods for estimating the protein concentration levels
from 1440-spot lysate arrays with 80 samples, three replicates, and six 2-fold
dilutions. In the first method, the median value of the the gray-intensity
levels for the three replicates is obtained at each dilution for each biolog-
ical sample. Suppose that the median observation at the lth dilution for
the ith sample is denoted by yi.l, typically on the log scale of the intensity
measurements. They assume the following linear model for each sample,
yi.l = γ1 + γ2 l + ²i.l,
where l = 1, 2, ..., 6, and apply the least squares regression to estimate γ1
and γ2. To compensate for the lack of robustness in the first method, they
propose the second method that uses all 18 measurements (3 replicates ×
6 dilution levels) and fits a linear model using a robust estimation for each
sample. For the ith sample, they assume the following linear model,
yijl = γ1 + γ2 l + ²ijl,
where j = 1, 2, 3, l = 1, 2, ..., 6, and then apply a robust method to estimate
γ1 and γ2. For both methods, the logarithm of the protein concentration
ratio is estimated as the distance between two fitted lines if the two lines
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are parallel. If the two lines are not parallel, the log-ratio is estimated as
the weighted distance between two fitted lines at each dilution. The weight
depends on the dispersion at that particular dilution: a dilution that has
a higher dispersion of three replicates is assigned a smaller weight and a
dilution that has a lower dispersion of three replicates is assigned a larger
weight.
However, it is generally believed that the intensity has a nonlinear rela-
tionship with the logarithm of true protein concentration level. Specifically,
the S-shape is expected because of both the background noise at the low
protein concentration level and the saturation intensity at the high protein
concentration level. In addition, it would be more reasonable to assume a
common curve for all the biological samples, because the identical antibody
to recognize the target protein is used for all the samples, and thus the target
protein in different samples reacts similarly to the antibody. In this case, a
joint estimation of the common curve using all the measurements of all the
samples will be more efficient than the separate estimation of the curve for
each sample.
A joint estimation assuming a common parametric curve is discussed in
[10]. They postulate several polynomial models and the Sigmoidal model for
dependence between the intensity level and the protein concentration level.
Among these models, they acknowledge that the Sigmoidal model generally
yields the best fit to lysate data. We introduce the procedure with the
Sigmoidal model, but the procedure with the polynomial model is similar.
The Sigmoidal model introduced in the previous section takes the form:
yijl = β1 +
β2
1 + e−β3(xi−l)
+ ²ijl,
where yijl is the gray-intensity level and xi is the logarithm of the protein
concentration. Their proposed method is based on the least squares esti-
mation: after the initial estimates of the concentration levels are obtained
(typically assuming a linear model), the estimations of the curve parameters
β, and of the concentration levels xi, are iteratively performed via nonlinear
least squares. The details are given below.
1. Consider a simple linear model, yijl = β0(xi− l)+ ²ijl, where β0 > 0,
which can be rearranged as follows:
yijl = β0(xi − l) + ²ijl
= γi − β0l + ²ijl,
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with γi = β0xi. Then we can find the least squares estimators, βˆ0 and
γˆi, i = 1, 2, ..., s, that minimize
s∑
i=1
r∑
j=1
t−1∑
l=0
(yijl − γi + β0l)2,
from which xˆi is obtained as γˆi/βˆ0, i = 1, 2, ..., s.
2. Given xi as xˆi, find the least squares estimators, βˆ1, βˆ2, and βˆ3 that
minimize
s∑
i=1
r∑
j=1
t−1∑
l=0
w2i
(
yijl − β1 − β21 + e−β3(xˆi−l)
)2
,
where wi can be set to zero to exclude the unreliable data points at
the spot quantification stage. Given β1, β2, and β3 as βˆ1, βˆ2, and βˆ3,
respectively, find the least squares estimator, xˆi that minimizes
r∑
j=1
t−1∑
l=0
w2i
(
yijl − βˆ1 − βˆ2
1 + e−βˆ3(xi−l)
)2
.
3. Iterate step 2 until the change in
∑s
i=1
∑r
j=1
∑t−1
l=0 w
2
i (yijl − βˆ1 −
βˆ2
1+e−βˆ3(xˆi−l)
)2 after an iteration becomes small enough.
In this method, however, the asymptotic behaviors of the final estimates
are not well studied, and the optimization over 3 + s parameters is subject
to the risk of missing the global minimum. Besides that, the model does
not take into consideration the dependence among the measurements, which
seems quite necessary when analyzing the lysate array data according to our
examination of real data.
Another approach, a nonparametric approach, is discussed in [13]. With-
out specifying a parametric form they propose the model,
yijl = g(xi − l) + ²ijl,
where g is a monotonically increasing function and the median of ²ijl is
assumed to be zero. After the initial estimates of the concentration levels
are obtained assuming a linear model, the estimations of the link function,
g, and of the concentration levels xi, are iteratively performed. The details
are given below.
1. Consider a linear model, yijl = α0 + α1(xi − l) + ²ijl. The estimator
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αˆ0 is obtained as the minimum of all the intensity measurements, αˆ1
is the median slope over all the dilution series, and xˆi is the median
of {(yijl − αˆ0 + αˆ1l)/αˆ1 : j = 1, 2, ..., r, l = 0, 1, ..., (t− 1)}.
2. Given xi as xˆi, find gˆ that, with a monotonicity constraint on g, min-
imizes
s∑
i=1
r∑
j=1
t−1∑
l=0
|yijl − g(xˆi − l)|+ λ maxx|g′′(x)|,
where λ is a smoothing parameter. Now given g as gˆ, find xˆi that
minimizes
r∑
j=1
t−1∑
l=0
|yijl − gˆ(xi − l)|.
3. Iterate step 2 until the change in
∑s
i=1
∑r
j=1
∑t−1
l=0 |yijl − gˆ(xˆi − l)|
after an iteration becomes small enough.
Even though the nonparametric approach of [13] is flexible without assum-
ing any parametric form, this method also involves estimating the parame-
ters of increasing dimensions because xi and g are estimated simultaneously
using all the measurements, which makes asymptotic inference of the final
estimators difficult. In addition, the dependence structure of data has not
been taken into account.
[14] discuss the asymptotic behavior of M -estimators when the dimen-
sion of the parameter space increases with the sample size. They show
that under certain regulatory conditions, M -estimators are consistent and
approximately normal if the dimension of the parameter space grows at a
controlled rate relative to the sample size. However, we find that it is hard
to apply their results directly to the protein lysate array with the Sigmoidal
model due to the difference in the convergency rates between the estimates
of xi and βk, k = 1, 2, 3. Note that we expect |xˆi − xi| = Op( 1√rt) and
|βˆk−βk| = Op( 1√srt), because only rt measurements are used to estimate xi,
while all srt measurements are used to estimate βk, k = 1, 2, 3. Then the
matrix that divides the elements of the Hessian matrix by the sample size,
srt, is not invertible and one of the regulatory conditions is not satisfied,
preventing us from directly applying their results to the protein lysate array.
A protein lysate array measures the relative concentration levels of a par-
ticular protein in many samples. Hence, in order to measure the levels of
more than one protein, people use a set of identically spotted arrays. Most
studies focus on the estimation of the concentration levels of a particular
protein by using within array information. Recent work of [15] proposes
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a model that takes into consideration the sample effect and the correla-
tion between proteins from several arrays. Additional studies are reported
in [2], [4] and [16]. However, neither asymptotic behaviors nor specific de-
pendence structures among the measurements within the same sample have
not been studied in those papers.
The asymptotic analysis plays an important role in statistics. It provides
a good basis for understanding the behaviors of an estimator and helps make
large sample inferences for statistical models. As far as we know, there is
not yet any asymptotic theory on protein quantification methods that can
be used to justify approximate inference procedures statistically. Chapter
2 aims to propose a method that guarantees a consistent estimator of the
protein concentration in the protein lysate array where the dimension of the
parameters increases with the sample size.
Most prior work on protein array quantification is based on the i.i.d. error
assumption, but the real data analysis often exhibits evidence against this
assumption. Misspecified models may lead to incorrect inference on an esti-
mator. In Chapter 3, we introduce a model that allows for the dependence
structure, and propose a method that can incorporate the complexity of the
correlation structure of data.
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CHAPTER 2
MULTI-STEP PROTEIN LYSATE ARRAY
QUANTIFICATION METHOD
2.1 Introduction
The protein lysate array is a developing technology for estimating the protein
concentration ratios in a large number of biological samples. Each sample is
serially diluted by a certain factor, spotted on a nitrocellulose-coated slide
in multiple replicates, and then bound with an antibody to measure the
amount of the protein of interest. As a result, a gray-level image is obtained
at each dilution level of each replicate for each sample. The dilution, as
well as the replicates, give several measurements for each sample, which
is a key characteristic of the protein lysate array from the quantification
point of view. In reality, the number of replicates, r, and the number of
dilution levels, t, are limited by time and cost constraints as compared with
the number of biological samples, s, particularly when we are interested in
measuring the protein concentration levels of a large number of biological
samples. A sensible large sample framework is to consider asymptotics as
both n (= rt) and s increase, which leads to a problem where the number
of unknown parameters grows with the available data points. It makes the
analysis of the protein lysate array a problem on parameters of increasing
dimensions. When we have this problem, finding a consistent estimator is
not straightforward. This statistical issue has not been dealt with in previous
work on protein lysate arrays, and it motivates our work. We propose a
multi-step least squares procedure as a modification of earlier methods of
protein quantification. The multi-step procedure applies the least squares
estimation to biological samples in small groups, and then uses a pooled
curve parameter estimate to recover efficiency.
The rest of this chapter is organized as follows. First, in Section 2.2,
we propose our multi-step procedure with two subtypes, depending on the
methods of pooling. In Section 2.3, we show the consistency and the asymp-
totic normality of the protein concentration estimates. In Section 2.4, we
evaluate the finite sample performance of the proposed procedure relative
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to the existing method of least squares, based on simulation studies. We
provide a confidence interval for the relative concentration level in the same
section. Real data analysis based on two different lysate arrays is given in
Section 2.5. Section 2.6 concludes the chapter.
2.2 Multi-Step Procedure
Throughout this chapter we assume the Sigmoidal model (1.1) introduced in
Section 1.2 for the relationship between the intensity level and the protein
concentration, which seems reasonable because the Sigmoidal model reflects
key characteristics of the lysate array data with background noise at the
lower end and the saturation at the higher end. Consider model (1.1) again:
yijl = β1 +
β2
1 + e−β3(xi−l)
+ ²ijl,
where β1, β2, β3 > 0. As we previously mentioned, β1 and β2 are interpreted
as the lowest intensity level and the increment from the lowest intensity level
to the saturation, respectively. We denote the curve parameters by β =
(β1, β2, β3)
′
. A suspicion that β1 and β2 could be inversely correlated leads
us to consider a reparameterization with a new parameter, γ = (β1 + β2),
and a new model,
yijl = β1 +
γ − β1
1 + e−β3(xi−l)
+ ²ijl, (2.1)
where γ > β1 > 0 and β3 > 0.
Based on model (1.1) and model (2.1), we now propose a multi-step pro-
cedure that is simpler both in theory and in computations, while achieving
full asymptotic efficiency of the concentration level estimates.
2.2.1 Procedure Details
Our modification has two components: a divide and conquer component and
a pooling component. In particular, we choose a small value of k, divide the s
biological samples into s/k (or its integer part) groups, use the least squares
method to estimate the parameters in each group, and then pool the curve
parameters from all groups, and finally, estimate xi for each sample based
on the pooled estimate of the curve parameters. The details of the modified
procedure are given as follows.
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Step 1 Grouping:
We combine k samples into one group, resulting in s/k groups and krt
measurements per group. In particular, we first find the median of
rt measurements for each biological sample and divide the s samples
into k categories so that the first category consists of the s/k samples
that have the smallest medians, the second category consists of the
s/k samples that have the next smallest medians, and so on. The last
category consists of the s/k samples that have the largest medians.
Then, randomly select one sample from each category to form a group,
where each group is comprised of k samples.
Step 2 Estimating parameters for each group:
Denote the curve parameters and the concentration levels of the qth
group by βq = (βq1, β
q
2, β
q
3)
′
and xq = (xq1, ..., x
q
k)
′
, respectively, where
q = 1, · · · , s/k. In addition, we use the notation yqijl for the measure-
ments of the ith sample in the qth group. Then, find the least squares
estimates, βˆ
q
and xˆq, that minimize
k∑
i=1
r∑
j=1
t−1∑
l=0
(
yqijl − βq1 −
βq2
1 + e−β
q
3(x
q
i−l)
)2
. (2.2)
Step 3 Pooling the curve parameter estimates:
Combine βˆ
q
linearly with an appropriate weight matrix so that the
pooled estimate is
βˆ
(c)
= (βˆ(c)1 , βˆ
(c)
2 , βˆ
(c)
3 )
′
=
∑
q
V qβˆ
q
,
where two types of weight matrices, V q, will be detailed in Section
2.2.2.
Step 4 Estimating the protein concentration level:
Given βˆ
(c)
, find the concentration estimate, x˜i, for the ith sample by
minimizing
r∑
j=1
t−1∑
l=0
(
yijl − βˆ(c)1 −
βˆ
(c)
2
1 + e−βˆ
(c)
3 (xi−l)
)2
. (2.3)
Because our proposed method employs an individual estimation for each
group, it might seem to use limited information from data. Pooling the
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estimates in Step 3, however, enables us to bring back information across
the groups. There is a trade-off between Step 2 and Step 3 as the size of
k varies. If k is small, the within-group variability is high, and thus the
curve parameter may not be estimated well in Step 2, but more groups are
available for pooling in Step 3 to regain efficiency. Based on our empirical
experience, k = 3 or 4 works reasonably well. In theory, any finite value of
k leads to the same asymptotic efficiency, but computational satiability is
easier to attain at a small value of k.
The strategy that we use for grouping in Step 1 allows us to estimate the
group-based curve parameter more stably. We divide the biological sample
into k categories according to the median of the measurements and then
randomly select one sample from each category to make a group. Then each
group can have measurements that cover a wider range of data, which can
make the group-based estimate more stable.
Our proposed method involves two optimization problems: one with 3+k
parameters in Step 2 and the other one with one parameter (at each time)
in Step 4, whereas the original least squares method solves an optimization
problem with 3 + s parameters. The lower dimensional parameter space in
our proposed method reduces the risk of missing the global minimum.
So far we illustrated our method using the original model (1.1). With
regard to the reparameterized model (2.1), every step will be identical except
βq2 = γ
q − βq1.
2.2.2 Weight Matrices
A proper weight matrix is needed to combine βˆ
q
, q = 1, 2, ..., s/k, and
two weight matrices are discussed in this section. We only use the original
Sigmoidal model in this section, but we can easily apply the results to the
reparameterized Sigmoidal model.
The first weight matrix, V q, q = 1, ..., s/k,minimizes the trace of var
(
βˆ
(c))
subject to
∑
q V
q = I3, where V q is a 3×3 matrix and I3 is the 3×3 identity
matrix. By using a result of [17], we obtain V q
V q = (
s/k∑
q=1
Ω−1q )
−1 Ω−1q ,
where Ωq is the variance-covariance matrix of βˆ
q
. Consider βˆ
∗
that mini-
12
mizes the following function N(β),
argmin
β
N(β) = argmin
β
s/k∑
q=1
(β − βˆq)′ Ω−1q (β − βˆ
q
).
It can be easily shown that
βˆ
∗
=
s/k∑
q=1
(
s/k∑
q=1
Ω−1q )
−1 Ω−1q βˆ
q
.
Therefore, minimizing N(β) leads to the exact same weight matrix as does
the trace-minimizing criterion.
Since V q is not necessarily a diagonal matrix, the variances of the curve
parameter estimates are treated jointly. However, the curve parameters,
β1, β2, and β3, are usually in different scales and var(βˆ3) is expected to be
smaller than var(βˆ1) and var(βˆ2). To treat each variance separately, we
may consider a diagonal weight matrix,
V q =
 C1 0 00 C2 0
0 0 C3
 ,
where Cm =
(∑s/k
q=1
(
var(βˆqm)
)−1)−1(
var(βˆqm)
)−1
, m = 1, 2, 3. We remark
that var(βˆqm) is the diagonal element of Ωq, which implies that the component-
wise minimization treats each variance component separately. In case an
estimated covariance matrix, Ωˆq, is singular, which poses problems in the
computation of the weight matrix, we use a weight of zero for the corre-
sponding βˆ
q
.
2.2.3 Variance-Covariance Matrix of Curve Parameter Estimates
In this section, we examine the covariance structure of estimated curve pa-
rameters. The variance-covariance matrix in the original Sigmoidal model,
cov(βˆ
q
), where βˆ
q
= ( βˆq1, βˆ
q
2, βˆ
q
3 )
′
, is considered first and then the
variance-covariance matrix in the reparameterized model, cov(Γˆ
q
), where
Γˆ
q
= ( βˆq1, γˆ
q, βˆq3 )
′
, is derived by modifying cov(βˆ
q
).
Consider the original Sigmoidal model with the objective function (2.2)
and denote the vector of the least squares estimators by θˆ
q
= ( βˆq1, βˆ
q
2, βˆ
q
3, xˆ
q
1, ... , xˆ
q
k )
′
.
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Then θˆ
q
is the solution to
r∑
j=1
t−1∑
l=0
ψ(yq1jl, y
q
2jl, ... , y
q
kjl, θ
q) = 0 , (2.4)
where ψ is vector-valued with the (3 + k) components:
[ψ]1 = −2
k∑
i=1
eqijl,
[ψ]2 = −2
k∑
i=1
eqijl
1
1 + e−β
q
3(x
q
i−l)
,
[ψ]3 = −2
k∑
i=1
eqijl
βq2(x
q
i − l)e−β
q
3(x
q
i−l)(
1 + e−β
q
3(x
q
i−l)
)2 ,
[ψ](u+3) = −2 eqijl
βq2β
q
3e
−βq3(xqu−l)(
1 + e−β
q
3(x
q
u−l))2 , u = 1, 2, ..., k,
where eqijl = y
q
ijl−βq1− β
q
2
1+e−β
q
3(x
q
i
−l) . By the sandwich formula for the standard
generalized estimating equations (GEE, [18]), we have
vq = var
(
θˆ
q)
= B−1q MqB
−1
q ,
where Bq and Mq are symmetric matrices of the following forms:
Bq = E
r∑
j=1
t−1∑
l=0
∂ψ
∂θq
= 2r
[
Bvw
]
1 ≤ v, w ≤ (3+k) and
Mq = var
r∑
j=1
t−1∑
l=0
ψ = 4rσ2
[
Mvw
]
1 ≤ v, w ≤ (3+k).
In Appendix A, we give the explicit expressions of Bvw and Mvw. Once vq
is calculated, the variance-covariance matrix of βˆ
q
can be obtained as
Ωq = var(βˆ
q
) = TvqT
′
,
where T is the following 3× (k + 3) matrix:
T =
 1 0 0 0 . . . 00 1 0 0 . . . 0
0 0 1 0 . . . 0
 . (2.5)
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In practice, the true values of βq, xq, and σ2 are unknown and have to be
replaced by their estimated values. We use βˆ
q
and xˆq, the estimates from
Step 2, to estimate σ2 by
̂(σ2)q = k∑
i=1
r∑
j=1
t−1∑
l=0
(
yqijl − βˆq1 −
βˆq2
1 + e−βˆ
q
3(xˆ
q
i−l)
)2/(
krt− (3 + k)
)
.
Now consider cov(Γˆ
q
) = cov
(
(βˆq1, γˆ
q, βˆq3)
′)
in the reparameterized Sig-
moidal model. Since γ = (β1 + β2), we have
cov
(
Γˆ
q)
= cov
(
(βˆq1, γˆ
q, βˆq3)
′)
= cov
(
Z (βˆq1, βˆ
q
2, βˆ
q
3)
′)
= cov
(
Z βˆ
q)
=
Z cov
(
βˆ
q)
Z
′
, and
̂
cov
(
Γˆ
q)
= Z ̂cov(βˆq) Z ′ ,
where
Z =
 1 0 01 1 0
0 0 1
 .
2.3 Asymptotic Properties
We first show the consistency of βˆ
(c)
, and then establish the asymptotic
normality of x˜i. We assume that the errors are independent and identically
distributed in Model (1.1). Only the original Sigmoidal model is considered
in this section, but the results can easily be modified for the reparameterized
model.
Consider the objective function (2.2) for the qth group in Step 2. We con-
tinue to use the notation θˆ
q
=
(
(βˆ
q
)
′
, (xˆq)
′)′
for the least squares estimates
that solve (2.4), and denote the true parameters by θqo =
(
(β
o
)
′
, (xqo)
′)′
=
(β1o, β2o, β3o, x
q
1o, ..., x
q
ko)
′
. Following [11], the Bahadur representation for
θˆ
q
is given by
√
n (θˆ
q − θqo) = C−1 D +
√
n Rqn ,
where
n = rt,
Rqn = op(n
−1/2),
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C = − 1
n
r∑
j=1
t−1∑
l=0
ψ˙(yq1jl, ..., y
q
kjl, θ
q
o),
D =
1√
n
r∑
j=1
t−1∑
l=0
ψ(yq1jl, ..., y
q
kjl, θ
q
o),
and ψ˙(yq1jl, ..., y
q
kjl, θ
q
o) =
[
∂ψ(yq1jl, ..., y
q
kjl, θ
q)
/
∂(θq)
′]|θq=θqo . Then it follows
that
βˆ
q
= β
o
+
1
n
T
r∑
j=1
t−1∑
l=0
ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o) + T R
q
n,
where T is a 3 × (3 + k) matrix given in (2.5), and ϕIF (yq1jl, ..., yqkjl, θqo) =
C−1 ψ(yq1jl, ..., y
q
kjl, θ
q
o). After combining the group-specific estimates, we
have
βˆ
(c)
=
s/k∑
q=1
V qβˆ
q
= β
o
+
1
n
s/k∑
q=1
r∑
j=1
t−1∑
l=0
V q T ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o) +
s/k∑
q=1
V q T Rqn.
Under conditions (A1)–(A3) as shown in Appendix B, we have the following
lemma.
Lemma 1. If conditions (A1)–(A3) are satisfied and n = rt, then
||βˆ(c) − β
o
|| = Op
(
(ns)−1/2
)
as n→∞ and s→∞.
Lemma 1 holds for both trace minimization criterion and component-wise
minimization criterion. The proof is also given in Appendix B.
Now consider the objective function (2.3) for the ith sample in Step 4.
The least squares estimate, x˜i, solves
r∑
j=1
t−1∑
l=0
φ(yijl, βˆ
(c)
, xi − l) = 0,
where
φ(yijl, βˆ
(c)
, xi − l) = −2
(
yijl − βˆ(c)1 −
βˆ
(c)
2
1 + e−βˆ
(c)
3 (xi−l)
) βˆ(c)2 βˆ(c)3 e−βˆ(c)3 (xi−l)(
1 + e−βˆ
(c)
3 (xi−l)
)2 .
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Then we have the following Bahadur representation for x˜i:
√
n (x˜i − xio) = 1√
n
r∑
j=1
t−1∑
l=0
ϕIC (yijl, βˆ
(c)
, xio − l) + op(1),
where
ϕIC (yijl, βˆ
(c)
, xio − l) =
(
− 1
n
r∑
j=1
t−1∑
l=0
φ˙(yijl, βˆ
(c)
, xio − l)
)−1
φ(yijl, βˆ
(c)
, xio − l),
and
φ˙(yijl, βˆ
(c)
, xio − l) =
[
dφ(yijl, βˆ
(c)
, xi − l)
/
dxi
]|xi=xio .
Theorem 1. If conditions (B1) given in Appendix C is satisfied, then
√
n(x˜i − xio)
/
sn
d→ N(0, 1) as n→∞ and s→∞,
where s2n = tσ
2
[∑t−1
l=0
(β2o)2(β3o)2e−2β3o(xio−l)(
1+e−β3o(xio−l)
)4 ]−1. The proof is given in Ap-
pendix C. We note that the asymptotic variance of x˜i is the same as that
under a model with known curve parameters.
Because βˆ
(c)
converges faster than the rate n−1/2, the estimates of xi in
Step 4 are as efficient as in a problem with known curve parameters. For
this reason, the estimator, x˜i achieves its full asymptotic efficiency. We
expect the same to be true for the least squares estimator of [10], but the
result is harder to verify. The single-stage method in [10] involves estimat-
ing the parameters of increasing dimensions because xi, i = 1, 2, ..., s, and
βm,m = 1, 2, 3, are estimated simultaneously using all the measurements,
which makes asymptotic inference of the final estimators difficult.
2.4 Simulation Studies
In this section, we carry out several simulation studies to evaluate the finite
sample performance of the proposed multi-step procedure in comparison
with a single-step least squares procedure on all the samples used in [10]
(to be denoted M-S hereafter). Our proposed procedure can be divided into
two subtypes depending on the methods of pooling. The first subtype, M-T,
uses the weight matrix that minimizes the trace of the variance-covariance
matrix, and the second subtype, M-C, uses the weight matrix that minimizes
the diagonal elements of the variance-covariance matrix. We have not found
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a big difference in the estimation results between the original Sigmoidal
model and the reparameterized Sigmoidal model, so we present only the
result based on the original model. In addition, we provide a confidence
interval for the relative concentration level by using the bootstrap methods
and the asymptotic theory developed in Section 2.3.
2.4.1 Algorithm Details
The proposed multi-step method combines k biological samples into one
group. In the simulation studies, we use three different k values: k = 2, 3,
or 4. When the estimated variance-covariance matrix is singular in Step
3, which makes the computation of the weight matrix impossible, we use a
weight of zero for the corresponding βˆ
q
. We use the R function solve with
the default tolerance level to determine singularity. Steps 2 and 4 of our
proposed method require nonlinear optimization. The R function optim is
used for the implementation with the following starting values.
In Step2:
1. As the starting value of β1, use the minimum of the intensity measure-
ments.
2. As the starting value of β2, use the range of the intensity measure-
ments. (as the starting value of γ in the reparameterized model, use
the maximum of the measurements).
3. As the starting value of β3, simply use a small ad hoc value 0.01.
4. As the starting values of xi, use the initial estimates of the concentra-
tion levels proposed in [10]. We center those values to have median
zero.
In Step4: As the starting values of xi, use xˆi, the estimates from Step 2.
Note that the Sigmoidal model has lower and upper asymptotes, which
means that if the xi’s lie in the tail area, they can hardly be distinguished
from the intensity measurements. For this reason, we Winsorize the final
estimates x˜i in both tails. Specifically, we compute
f(x) = βˆ(c)1 +
βˆ
(c)
2
1 + e−βˆ
(c)
3 x
,
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and then find x∗ > 0 such that f ′(x∗) = z, for a slope threshold value z.
Then all the points x˜i that satisfy x˜i > x∗ are Winsorized to x∗, and all the
points x˜i that satisfy x˜i < −x∗ are Winsorized to −x∗. The slope threshold,
z, is chosen as 0.05% of the range of the intensity measurements. This choice
of z is ad hoc, supported by our empirical experience with lysate array data.
For the single-stage method used in [10], the same starting values of
β1, β2, β3 and xi as given above are used and the R function optim is em-
ployed in the implementation. Also the same Winsorization rule is applied.
2.4.2 Assessment Criteria
The aim of the simulation studies is to evaluate how well the relative con-
centration levels are estimated. [13] provide a relevant summary and we use
the same idea with suitable modifications. We perform M simulation tri-
als, and for each trial we find as a reference the biological sample whose
true concentration level is the median of s true levels. Then, for that trial
compute Dtot as defined by
Dtot =
s∑
i=1
|D˜i −Di|,
where D˜i = x˜i − x˜ref , Di = xi − xref , x˜i and x˜ref are the estimates
for the concentration levels of the ith sample and of the reference sample,
respectively, and xi and xref are their true values. The smaller Dtot is, the
more desirable the result is.
2.4.3 Simulation Case 1
In the first case, we intend to mimic the result of the real data analysis
performed in [10] in order to reflect a realistic situation. The lysate array for
the protein pThr308AKT has been analyzed in [10], and we use the result as
a reference when generating simulation data sets. The array pThr308AKT
is accessible online (http://www.cs.tut.fi/∼tabus/lysate/).
We generate data from Model (1.1) with (β1, β2, β3) = (10, 6, 0.5). A total
of 96 samples are used with r = 3 dilution series of length l = 8 for each
sample. The log scale of the true concentration levels, xi, are generated
from the uniform distribution on the interval (−1.5, 8.5), and then all the
dilution series, (xi − l), l = 0, 1, ..., 7, range within the interval (−8.5, 8.5).
The independent error terms, ²ijl, are chosen to be the normal with mean 0
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and variance 0.15. Note that xi is the highest concentration level for each
dilution series. Thus even if xi’s are generated from a uniform distribution,
the dilution series, xi − l are not uniformly distributed.
Figure 2.1 shows the distributions of Dtot based on 100 Monte Carlo data
sets, using the Box-and-Whisker plot. The first panel corresponds to k = 2,
the second panel corresponds to k = 3 and the third panel corresponds to
k = 4. When k = 3 or 4, M-C and M-T lead to smaller maxima and smaller
medians than M-S, and this can be more clearly seen in Table 2.1, where
we present the summary statistics of Dtot. We see that M-S has a very
large maximum, indicating occasional instability when the optimization is
carried out in a higher dimensional parameter space. The results of M-C
and M-T are generally better when k = 3 or 4 than when k = 2 although
the difference is marginal.
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Figure 2.1: Box-and-Whisker plots of Dtot in Case 1. M-C and M-T are
the multi-step procedures using component-wise minimization and trace
minimization, respectively. M-S is the one-step least squares method.
We may examine the estimation result of the curve parameters, βm, m =
1, 2, 3, based on 100 Monte Carlo data sets. Table 2.2 shows the summary
statistics of 100 estimates. The result when k = 4 is given. The M-S method
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Table 2.1: Summary statistics of Dtot in Case 1.
k = 2 k = 3 k = 4
M-C M-T M-C M-T M-C M-T M-S
Min 12.56 10.93 11.74 11.12 11.10 11.38 11.25
Median 20.69 20.19 18.92 18.81 18.93 18.67 20.35
Mean 22.24 21.68 20.70 20.40 20.54 20.37 22.48
Max 45.13 42.39 42.05 41.70 42.45 41.30 66.46
Table 2.2: Estimation result for the curve parameters in Case 1. The true
value of (β1, β2, β3) is (10, 6, 0.5).
M-C M-T M-S
β1 Min 9.95 9.93 0.00
Median 10.03 10.02 9.99
Mean 10.03 10.02 9.28
Max 10.13 10.13 10.15
MSE 0.00 0.00 4.91
β2 Min 5.81 5.82 5.86
Median 5.94 5.97 6.03
Mean 5.94 5.97 8.15
Max 6.10 6.11 31.16
MSE 0.01 0.01 33.71
β3 Min 0.48 0.48 0.06
Median 0.50 0.50 0.50
Mean 0.50 0.50 0.42
Max 0.52 0.53 0.52
MSE 0.00 0.00 0.03
often produces very poor curve estimates. The mean squared error is also
given in Table 2.2, and M-S produces large mean squared errors for all three
parameters.
2.4.4 Simulation Case 2
In the second case, we generate data from the Sigmodial model with (β1, β2, β3) =
(1, 1.5, 2). A total of 480 samples are used with r = 3 dilution series of length
l = 6 for each sample. The error distribution is chosen to be normal with
mean 0 and variance (0.14)2. The true values of xi are taken from the empir-
ical distribution of the 96 estimated xˆi values from the array pThr308AKT
used in [10].
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Table 2.3: Summary statistics of Dtot in Case 2.
k = 2 k = 3 k = 4
M-C M-T M-C M-T M-C M-T M-S
Min 239.4 240.4 245.2 245.4 242.7 244.8 259.2
Median 264.4 264.9 266.0 267.3 262.1 264.1 280.5
Mean 268.9 268.9 270.0 271.4 267.1 268.3 284.6
Max 369.6 372.6 367.4 369.8 371.5 373.2 387.3
Figure 2.2 shows the the distributions of Dtot based on 500 Monte Carlo
data sets. We note that M-C and M-T have lower values of Dtot, which
can be more clearly seen in Table 2.3. If we compare data set by data
set, the percentage of out-performance of M-C over M-S is 97.6%, and the
percentage of out-performance of M-T over M-S is 98.2% in terms of Dtot.
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Figure 2.2: Box-and-Whisker plots of Dtot in Case 2.
Table 2.4 shows the summary statistics of 500 estimates for the curve
parameters. For all three procedures, the parameters are very accurately
estimated. The true values of β1, β2, β3 are 1, 1.5, and 2, respectively.
22
Table 2.4: Estimation result for the curve parameters in Case 2. The true
value of (β1, β2, β3) is (1, 1.5, 2).
M-C M-T M-S
β1 Min 0.99 0.99 0.99
Median 1.00 1.00 1.00
Mean 1.00 1.00 1.00
Max 1.01 1.01 1.01
MSE 0.00 0.00 0.00
β2 Min 1.48 1.49 1.49
Median 1.50 1.50 1.51
Mean 1.50 1.50 1.50
Max 1.52 1.52 1.52
MSE 0.00 0.00 0.00
β3 Min 1.87 1.87 1.93
Median 1.94 1.96 2.00
Mean 1.94 1.96 2.00
Max 2.02 2.03 2.06
MSE 0.00 0.00 0.00
2.4.5 Simulation Case 3
In the third case, we generate the concentration levels from a skew-normal
distribution. From Figure 2.3, we find that the skew-normal distribution
with location, scale, and shape parameters (3,2,-3) matches closely the em-
pirical distribution of xi estimates from real data analysis. The top two
panels in Figure 2.3 show the empirical distributions of xi estimates for the
array of the protein pThr308AKT : log transformation of data is applied in
the left panel and no transformation is applied in the right panel. We will
discuss the transformation of data in details later in Section 2.5. A bump
in the lower tail occurs due to the Winsorization. The bottom two panels
show the empirical distributions of xi estimates for the arrays of AKT and
pmTor. The solid line in all panels represents the skew-normal distribution
with location, scale, and shape parameters (3,2,-3). In this case, we use
β1 = 1, β2 = 1.5, β3 = 1, s = 96, r = 3, l = 6. The error terms are generated
again from the normal distribution with mean zero and variance (0.14)2.
Figure 2.4 shows the distributions of Dtot based on 500 Monte Carlo data
sets. The M-C and M-T procedures (when k = 4) lead to smaller Dtot
overall. It can be more easily seen in Table 2.5. If we compare case by case,
M-C outperforms M-S in 60.2% of the time, and M-T outperforms M-S in
65.6% of the time in terms of Dtot.
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Figure 2.3: The empirical distribution of xi estimates (the dashed line)
versus the skew-normal distribution with location, scale, and shape
parameters (3,2,-3) (the solid line). a) The empirical distributions of xi
estimates in the top two panels are based on the array of pThr308AKT
(log transformation of data is applied in the left panel and no
transformation is applied in the right panel). b) The empirical
distributions of xi estimates in the bottom two panels are based on the
arrays of AKT and pmTor.
Table 2.5: Summary statistics of Dtot in Case 3.
k = 2 k = 3 k = 4
M-C M-T M-C M-T M-C M-T M-S
Min 9.47 9.84 9.31 9.52 9.30 9.43 9.20
Median 15.65 15.87 15.14 14.91 14.96 14.72 15.78
Mean 16.66 17.06 16.25 16.05 16.09 15.89 17.07
Max 35.76 40.90 34.97 34.72 34.30 34.68 42.38
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Figure 2.4: Box-and-Whisker plots of Dtot in Case 3.
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Table 2.6: Estimation result for the curve parameters in Case 3. The true
value of (β1, β2, β3) is (1, 1.5, 1).
M-C M-T M-S
β1 Min 0.98 0.89 0.64
Median 1.01 1.00 0.84
Mean 1.01 1.00 0.86
Max 1.04 1.03 1.02
MSE 0.00 0.00 0.03
β2 Min 1.38 1.41 1.50
Median 1.46 1.49 2.70
Mean 1.46 1.50 2.49
Max 1.54 1.83 3.30
MSE 0.00 0.00 1.24
β3 Min 0.90 0.55 0.39
Median 0.98 0.98 0.49
Mean 0.98 0.98 0.58
Max 1.08 1.07 1.04
MSE 0.00 0.00 0.21
Closer inspections show that the M-S method often produces poor curve
estimates as shown in Table 2.6. On the other hand, M-C and M-T give
quite accurate estimates for the curve parameters with very small mean
squared errors.
2.4.6 Simulation Case 4
In this case, we generate data from the Sigmoidal model with β1 = 5, β2 =
1.5, β3 = 2, and the error distribution of N(0, 0.142). Each data set consists
96 samples, each of which consists of r = 3 dilution series of length l =
6. The values of xi are generated from the skew-normal distribution with
location, scale, and shape parameters (4,2,-2). We see in Figure 2.5 that this
skew-normal distribution matches quite closely the empirical distribution of
xi estimates from real data analysis.
Figure 2.6 shows the the distributions of Dtot based on 500 Monte Carlo
data sets. When k = 4, M-C and M-T have lower values of Dtot than
M-S. If we compare case by case, M-C outperforms M-S in 75.8% of the
time, and M-T outperforms M-S in 77.4% of the time in terms of Dtot. The
performance of M-T significantly improves when we combine more samples
into one group.
As for the curve parameters, M-S often gives very poor estimates as shown
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Figure 2.5: The empirical distribution of xi estimates (the dashed line)
versus the skew-normal distribution with location, scale, and shape
parameters (4,2,-2) (the solid line). a) The empirical distributions of xi
estimates in the top two panels are based on the array of pThr308AKT
(log transformation of data is applied in the left panel and no
transformation is applied in the right panel). b) The empirical
distributions of xi estimates in the bottom two panels are based on the
arrays of AKT and pmTor.
Table 2.7: Summary statistics of Dtot in Case 4.
k = 2 k = 3 k = 4
M-C M-T M-C M-T M-C M-T M-S
Min 2.73 3.21 2.80 2.88 2.91 2.81 3.90
Median 10.39 10.43 9.53 9.38 8.52 8.31 34.64
Mean 11.29 17.60 10.44 12.54 9.57 10.16 34.12
Max 38.17 288.07 35.93 246.55 35.45 105.22 166.63
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Figure 2.6: Box-and-Whisker plots of Dtot in Case 4.
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Table 2.8: Estimation result for the curve parameters in Case 4. The true
value of (β1, β2, β3) is (5, 1.5, 2).
M-C M-T M-S
β1 Min 4.98 4.88 0.00
Median 5.00 5.00 3.98
Mean 5.00 5.00 4.02
Max 5.02 5.02 5.03
MSE 0.00 0.00 1.92
β2 Min 1.46 1.47 1.47
Median 1.50 1.50 5.06
Mean 1.50 1.50 4.49
Max 1.54 1.72 13.23
MSE 0.00 0.00 15.49
β3 Min 1.83 0.54 0.08
Median 1.96 1.97 0.25
Mean 1.96 1.96 0.84
Max 2.11 2.14 2.15
MSE 0.00 0.02 2.07
in Table 2.8. On the other hand, our method (M-C and M-T) provides quite
accurate estimates with very small mean squared errors.
2.4.7 Asymptotic Variance Estimates for Concentration Level
Estimates
In order to assess the uncertainty of xi estimate, we need to compute the
variance of the estimate. A valid variance computation of xi estimate is
not given in [10]. In this section, we provide an asymptotic variance of xi
estimate using the asymptotic theory developed in Section 2.3. In addition,
we evaluate the accuracy of the asymptotic variance estimates by comparing
them with the Monte Carlo variances.
Monte Carlo Variances
We generate M Monte Carlo samples by randomly drawing the error terms
from their true distribution, and for each Monte Carlo sample, we estimate
xi. The sample variance of M estimates for xi, the Monte Carlo variance,
will be used as a benchmark for evaluating the accuracy of the asymptotic
variance estimate for xi estimate. All Monte Carlo data sets share the
identical set of xi (i = 1, · · · , s), which is designed to make the comparison
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among the Monte Carlo data sets possible.
Asymptotic Variance Estimates
By Theorem 1, we have
v̂ar(x˜i) = σˆ2
[
r
t−1∑
l=0
(βˆ(c)2 )
2(βˆ(c)3 )
2e−2βˆ
(c)
3 (x˜i−l)(
1 + e−βˆ
(c)
3 (x˜i−l)
)4
]−1
,
where βˆ(c)1 , βˆ
(c)
2 and βˆ
(c)
3 are the pooled curve parameter estimates in Step 3,
x˜i is the final concentration level estimate in Step 4 of our proposed method,
and
σˆ2 =
s∑
i=1
r∑
j=1
t−1∑
l=0
(
yijl − βˆ(c)1 −
βˆ
(c)
2
1 + e−βˆ
(c)
3 (x˜i−l)
)2/(
srt− (3 + s)).
Based on this result, we compute v̂ar(x˜i) for each Monte Carlo sample, and
use the average of those variance estimates to see how close they are to the
Monte Carlo variances.
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Figure 2.7: Monte Carlo variance versus average asymptotic variance
estimate.
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Figure 2.8: True curve and true xi values: the points with the triangle
symbol correspond to the six outliers in Figure 2.7.
The simulation setting of Case 1 is used when generating 100 Monte Carlo
data sets. Figure 2.7 shows the average asymptotic variance estimate and
the Monte Carlo variance of x˜i along with the 45-degree line. The first panel
includes the variances for all x˜
′
is, and we note that for six x˜
′
is (represented
with the triangle symbol), the asymptotic variance is underestimated. The
second panel excludes these six outliers. Overall the average asymptotic
variance estimates are close to the Monte Carlo variances with a few excep-
tions. The correlation coefficient between the average asymptotic variance
estimates and the Monte Carlo variances for all the points is 0.54 and the
correlation coefficient without six outlying points is 0.86. Figure 2.8 shows
the true xi on the true curve. The six outliers are again represented with the
small triangles. To have a clearer look, the six points are shifted downwards
slightly from the curve. As shown in Figure 2.8, the true xi values for the six
outliers are all near the tail area, which implies that an accurate estimation
of the concentration level is more difficult in the tails than in the middle.
2.4.8 Confidence intervals
Finally, we consider a confidence interval for the relative concentration level
using the bootstrap-t method ( [19]). For each biological sample, we boot-
strap r dilution series B times and compute a 100 (1 − 2α)% confidence
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interval on pairwise difference as follows:
CI1 =
(
ηˆi − sˆe(ηˆi) qˆ∗sn(1− α), ηˆi − sˆe(ηˆi) qˆ∗sn(α)
)
,
where ηˆi = xˆi− xˆref , and qˆ∗sn(α) is the αth sample quantile of the re-sampled
statistics, {T ∗sn,1, ..., T ∗sn,B} with T ∗sn = (ηˆ∗i − ηˆi)/se(ηˆ∗i ), and se(ηˆ∗i ) is the
standard error of ηˆ∗i calculated from the bootstrap sample. We use the
asymptotic result of Theorem 1 to obtain sˆe(ηˆi) = v̂ar(xˆi− xˆref )1/2, that is,
v̂ar(xˆi−xˆref ) = σˆ2
[
r
t−1∑
l=0
βˆ22 βˆ
2
3e
−2βˆ3(xˆi−l)(
1 + e−βˆ3(xˆi−l)
)4]−1+σˆ2[r t−1∑
l=0
βˆ22 βˆ
2
3e
−2βˆ3(xˆref−l)(
1 + e−βˆ3(xˆref−l)
)4]−1,
where the estimated values of β and xi are used, and
σˆ2 =
s∑
i=1
r∑
j=1
t−1∑
l=0
(
yijl − βˆ1 − βˆ2
1 + e−βˆ3(xˆi−l)
)2/(
srt− (3 + s)).
We shall denote as CI1 the bootstrap confidence intervals described above.
As shown in Lemma 1, the convergence rate of the curve parameter estimate
is faster than that of the concentration estimate, and hence we may construct
bootstrap confidence intervals by retaining the curve parameter estimate
from the original data. This confidence interval, to be called CI2, computes
only the estimates of the concentration levels at each bootstrap sample, and
therefore is much less computationally intensive than CI1.
Based on the simulation setting of Case 3, we compute 90% bootstrap
confidence intervals with 100 Monte Carlo data sets and the bootstrap size
of B = 100. For each data set, we compute bootstrap confidence intervals
for 95 pairwise differences (xi − xref , i = 1, 2, ..., 96, i 6= ref), where the
reference sample is taken to be the sample with the median concentration
level. The coverage probability is the proportion of the intervals that contain
the true values among all 95 × 100 intervals. In addition, we obtain the
average interval length for each of the 95 pairwise differences. Using CI2,
the coverage probabilities of M-C, M-T, and M-S are 0.89, 0.89, and 0.88,
respectively. As shown in Table 2.9, M-C and M-T have shorter confidence
intervals than the M-S procedure on the average. Figure 2.9 displays the
distribution of the interval length using the Box-and-Whisker plot. Overall,
M-C and M-T result in shorter confidence intervals than M-S.
According to the result of Theorem 1, the concentration level estimates
have the asymptotic normality, so we may consider an asymptotic confi-
dence interval for the relative concentration level. Using the same Monte
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Table 2.9: Coverage probabilities and average interval lengths based on
simulation Case 3: the nominal level is 0.90.
M-C M-T M-S
Bootstrap CI Coverage prob 0.89 0.89 0.88
Avg interval length 0.66 0.65 0.71
Asymptotic CI Coverage prob 0.90 0.89 0.89
Avg interval length 0.68 0.67 0.74
Carlo data sets as with the bootstrap confidence intervals, we compute 90%
asymptotic confidence intervals for 95 pairwise differences. The coverage
probabilities of M-C, M-T, and M-S are 0.90, 0.89, and 0.89, respectively.
Again, as shown in Table 2.9, the average interval lengths of M-C and M-T
are shorter than M-S. The asymptotic and the bootstrap confidence intervals
produce very similar results.
For both bootstrap and asymptotic confidence intervals, two samples in
the tails are excluded from computation.
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Figure 2.9: Box-and-Whisker plots of the bootstrap confidence interval
length based on simulation Case 3.
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2.5 Real Data Analysis
Now we present the results of real data analysis based on two different
lysate arrays. The first array, the lysate array of the protein pThr308AKT
is mentioned in Section 3.4.1. In this array, 96 samples are 2-fold serially
diluted 6 times and spotted on a slide in triplicate. Accordingly, there
are 1728 = 96 · 3 · 6 intensity measurements, but 15 measurements are not
reliable because the spot intensities are lower than the background intensity
and hence these measurements are not used for analysis. We apply both
the proposed multi-step method (M-C with k = 4) and the existing least
squares method (M-S) to this array.
Before that, we examine carefully the usefulness of data transformation.
In Model (1.1), we assume the Sigmoidal relationship between the intensity
level and the log-transformed concentration level. However, log transforma-
tion is often applied to the intensity level, too. In [10], log transformation
is used for the intensity level and then a positive scalar is added to the
log-transformed intensity level to ensure positive values. A statistical cri-
terion for choosing an appropriate transformation is the comparison of the
likelihoods. Suppose that we have
h(yijl) = g(β, xi − l) + ²ijl
= β1 +
β2
1 + e−β3(xi−l)
+ ²ijl,
where yijl is the intensity level and xi is the logarithm of the protein con-
centration level with base 2. A link function, h, is assumed to take one of
the following forms:
h(yijl) =
{
yijl
log(yijl + c)
where c is positive number chosen to ensure positive values in all h(yijl). We
assume that ²ijl are independent and identically distributed (i.i.d.) following
the normal distribution with mean zero and variance σ2. Then the log-
likelihood function is given by
l(β, xi, σ2) = −srt2 log(2piσ
2)− 1
2σ2
∑
ijl
(
yijl − g(β, xi − l)
)2
,
if h is the identity function and
l(β, xi, σ2) = −srt2 log(2piσ
2)− 1
2σ2
∑
ijl
(
log(yijl + c)− g(β, xi − l)
)2 −∑
ijl
log(yijl + c),
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if h is the log function.
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Figure 2.10: Log-likelihood function for pThr308AKT array: the solid line
and the star correspond to log transformation and no transformation,
respectively.
Figure 2.10 plots the log-likelihood values computed with different trans-
formations using M-C and M-S for the pThr308AKT array. The solid line
indicates the log-likelihood for the log transformation with c ∈ [1, 5] and
the star indicates the log-likelihood for the identity link, that is, no trans-
formation. We see that no transformation has a higher log-likelihood than
the log transformation does. The maximum of the log-likelihood with log
transformation occurs at about c = 1 for both methods. We present the
estimation results of no transformation and the log transformation with
c = 1 in Figure 2.11. The left column corresponds to no transformation
and the right column corresponds to the log transformation with c = 1.
Top two rows display data points and fitted curves, where the x-axis is the
median-centered concentration estimates. The fitted curves are adjusted ac-
cordingly to the median centering. Both methods fit the data reasonably
well and give similar curve fits for either transformation. In fact, the curve
parameter estimates are fairly close for two methods: with no transforma-
tion the estimates of M-C are (0.11, 1.99, 0.67) and the estimates of M-S are
(0.11, 1.91, 0.75), while with the log transformation the estimates of M-C are
(0.12, 1.49, 0.59) and the estimates of M-S are (0.15, 1.19, 0.92). The bottom
row in Figure 2.11 compares the relative concentration level estimates using
two methods for each transformation. The relative concentration estimate
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Figure 2.11: The left column corresponds to no transformation and the
right column corresponds to the log transformation with c = 1 for
pThr308AKT array. Top two rows show data points and fitted curves and
the bottom row compares the relative concentration level estimates using
two methods. 36
is given by xˆi − xˆref , i = 1, 2, ..., s, where xˆi and xˆref are the concentration
estimates of the ith sample and a reference sample, respectively. We use the
middle sample based on the intensity measurements as the reference sample.
We expect s dots to be close to the 45-degree line if the estimation results
of two methods are similar, and indeed two methods yield the very similar
estimates for both transformations as shown in this figure. It is not atypical
that the proposed multi-step procedure and the least squares method on all
samples give similar results, when both methods find the global optima in
the nonlinear least squares.
In the lysate array of the protein AKT , 40 samples are diluted 2-fold eight
times and spotted on a slide in duplicate and all the measurements are used
for analysis. A detailed layout of this array can be found in [13]. Figure 2.12
shows the results based on AKT array. We first see that no transformation
leads to a substantially larger log-likelihood than log transformation does.
Therefore, we only present the result of no transformation and as shown
in Figure 2.12, M-C and M-S fit the data very well and give similar fitted
curves and concentration estimates. The curve parameter estimates are
(472.06, 21801.42, 0.58) for M-C and (239.60, 21122.32, 0.63) for M-S.
Next, we compute the confidence intervals for the relative concentration
levels using the bootstrap methods described in the previous section. The
bootstrap size is 400, and the confidence level is chosen to be 90%. We
construct two types of the bootstrap confidence intervals (CI1 and CI2) for
xi−xref , i = 1, ..., 96, i 6= ref, using M-C and M-S, and then assess how often
the different procedures lead to the same conclusion regarding the signs of
xi−xref . Since the number of replicates is too small in AKT array (r = 2),
we use the pThr308AKT array. The 3× 3 contingency tables in Table 2.10
cross classify 95 intervals by the signs of the intervals that are obtained under
different procedures. The sign has three levels depending on whether the
interval contains only negative values (−), or contains zero (Not significant),
or only positive values (+). The first contingency table compares CI1 using
M-C with CI1 using M-S. They agree very well and no opposite signs are seen
from CI1 and CI2. The second and the third contingency tables compare
CI1 and CI2 within each method. As we see, CI1 and CI2 agree perfectly
for both M-C and M-S. Table 2.11 shows the bootstrap confidence intervals
corresponding to the off-diagonal entries in the first contingency table in
Table 2.10. We do not see considerable differences in those intervals even
when the signs do not match exactly. With real data, we cannot be sure
about the coverage probabilities of those confidence intervals. To see the
interval length, we use Figure 2.13, where we display the distribution of the
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interval length using the Box-and-Whisker plot. Overall, the M-C procedure
results in shorter confidence intervals than M-S, which is consistent with
what we learned from the simulation study in the previous section. Ten
samples in the tails are excluded from this figure.
2.6 Conclusion
In this article, we consider a modified multi-step procedure for lysate array
quantification based on the Sigmoidal model. Our modification from the
least squares method of [10] simplifies both theory and computations. In
theory, the modification enables us to verify asymptotic normality of the
protein concentration estimates as the number of biological samples and the
number of measurements per sample grow, thus providing a theoretical foun-
dation for statistical inference. In computation, the modification employs
the nonlinear optimization in lower parameter spaces, reducing the risk of
being trapped in local minima. For most data sets, the least squares method
and our proposed modification produce very similar results, but the advan-
tages of a simpler asymptotic theory and better numerical stability in some
of the data sets make the modification worthwhile. The proposed method
will be more valuable in applications where the total number of samples, s,
on the protein array is large.
We have focused on the specific Sigmoidal model in the paper with i.i.d.
errors. The basic principle of grouping and pooling in the multi-step proce-
dure applies readily to other models. Relaxation of the i.i.d. errors assump-
tion is quite important. One attempt to allow for non-i.i.d. errors is given
in the next chapter.
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Figure 2.12: The upper left corner corresponds to the log-likelihood
function (the solid line is for log transformation and the star is for no
transformation), the upper right corner corresponds to the comparison of
the relative concentration level estimates, and the bottom row shows data
points and fitted curves using two methods (without transformation) for
AKT array.
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Table 2.10: Contingency table categorized by the signs of the intervals
using two different ways for pThr308AKT .
CI1 using M-S
CI1 using M-C − Not significant + Total
− 34 3 0 37
Not significant 0 18 0 18
+ 0 0 40 40
Total 34 21 40 95
CI2 using M-C
CI1 using M-C − Not significant + Total
− 37 0 0 37
Not significant 0 18 0 18
+ 0 0 40 40
Total 37 18 40 95
CI2 using M-S
CI1 using M-S − Not significant + Total
− 34 0 0 34
Not significant 0 21 0 21
+ 0 0 40 40
Total 34 21 40 95
Table 2.11: Bootstrap confidence intervals for xi − xref that correspond to
the off-diagonal entries in the first contingency table in Table 2.10.
CI1 using M-C CI1 using M-S
(−0.68,−0.03) (−0.65, 0.02)
(−0.69,−0.03) (−0.40, 0.28)
(−1.16,−0.50) (−0.59, 0.15)
40
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Figure 2.13: Box-and-Whisker plots of the confidence interval length for
pThr308AKT . The first two columns are for the confidence intervals CI1
under M-C and M-S procedures, and the last two columns are for the
confidence intervals CI2.
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CHAPTER 3
PROTEIN LYSATE ARRAY QUANTIFICATION
METHOD UNDER NON -I.I.D. MODEL
3.1 Introduction
Previous studies of protein array quantification including [10] are based on
the assumption that the errors are independent. However, when we exam-
ine the residuals obtained under the i.i.d. error assumption, this assumption
appears very questionable. The nature of the experiment warrants the ex-
istence of correlation, too. The repeated measurements of each biological
sample are likely to be correlated. Also the measurements within dilution
series come from the same replicate of the same biological sample, and are
thereby likely to have correlation. In this chapter, we consider the complex-
ity of the correlation structure, and introduce a new model that can allow for
the dependence structure of the errors by a nonlinear mixed effects model.
Based on the new model, we consider a method to approximate the joint
maximum likelihood estimator of all the parameters. We show empirically
that the new model is valuable for the protein lysate array quantification.
In future work, we will employ two other methods that may improve com-
putational efficiency and stability. The first is the EM algorithm and the
second is a Bayesian approach with MCMC. In addition, we will develop an
asymptotic theory on the joint maximum likelihood estimator based on the
new model.
The rest of this chapter is organized as follows. In Section 3.2, we raise
concerns about the i.i.d. error assumption based on the examination of real
data, and introduce a model that allows for the dependence structure. In
Section 3.3, we propose a method to approximate the joint maximum like-
lihood estimator. As preliminary studies, simulated data and real data are
analyzed in this section. In Section 3.4, we perform several simulation stud-
ies to evaluate the performance of the proposed method, in comparison with
the existing method. Future work is discussed in the same section.
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3.2 Non-IID Model
Most prior work on protein array quantification is based on the assumption
that the errors are independent. The single-step least squares procedure
of [10] that is many times cited in the literature works when the errors are
i.i.d. In this section, we raise concerns about this assumption based on the
examination of real data, and introduce a model that allows for dependence
in the data.
3.2.1 Motivation
We examine the empirical residuals after applying the single-step least squares
procedure discussed in [10] on two arrays for the protein AKT and the pro-
tein pmTor. These arrays were produced at M.D. Anderson and for both
arrays, 40 biological samples are 2-fold serially diluted eight times and spot-
ted on a slide in duplicate. A detailed layout is described in [13].
A statistical criterion for measuring the correlation between two random
vectors is canonical correlation, which is the maximum correlation between
linear combinations of the two vectors ( [20]). If we treat the residuals from
a dilution series as a random vector, then canonical correlation between
two sets of the residuals from two dilution series of a certain biological
sample can be thought of as the correlation between two replicates within the
sample. For both arrays, we computed the canonical correlations between
two dilution series and we obtained 0.92 for AKT array, 0.96 for pmTor
array. They indicate that the replicates within the sample may be highly
correlated. In addition, Figure 3.1 shows that the residuals from two dilution
series are highly linearly correlated. The first panel presents the residuals of
40 samples at the first dilution level for AKT array, and the second panel
presents the residuals of 40 samples at the fourth dilution level for pmTor
array.
These findings lead us to consider a new model that allows for non-i.i.d.
error structures, which will be discussed in the next section.
3.2.2 Mixed Effects Model
In this section, we introduce a model that takes into account a possible
dependence structure of the lysate array data. We assume the Sigmoidal
curve for the relationship between the concentration level and the intensity
measurements. However, unlike in Chapter 2, we assume that there are
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Figure 3.1: The residuals from two dilution series of 40 samples for AKT
array and pmTor array.
random effects of the dilution series nested within sample. In addition,
we assume heteroscedastic measurement errors for different dilution levels.
Consider the following model:
yijl = g(β, xi − l) + δij + ²ijl, (3.1)
where i = 1, ..., s, j = 1, ..., r, l = 0, ..., (t − 1), yijl is the intensity
measurement at the lth dilution of the jth replicate for the ith sample,
xi is the logarithm of the protein concentration of the ith sample, and
g(β, xi − l) = β1 + β21+e−β3(xi−l) . We use the notation, δij for the ran-
dom effect of the jth replicate, nested within the i sample, but assumed to
be independent for different samples. We assume that the random effects,
δij , are independent of the errors, ²ijl. In addition, δij are assumed to be
correlated for different replicates. Assume that δi = (δi1, · · · , δir)′ follows
the normal distribution:
δi ∼ Nr
(
0, Vδ
)
,
44
where Vδ is an r × r matrix taking the form,
Vδ = σ2δ

1 ρ . . . ρ
ρ 1 . . . ρ
· · ·
ρ ρ . . . 1
 .
For the error terms, ²ijl, we assume that they are mutually independent and
²ij = (²ij0, ..., ²ij(t−1))
′
follows the normal distribution:
²ij ∼ Nt
(
0, V²
)
,
where V² is a t× t matrix taking the form,
V² =

σ2²0 0 . . . 0
0 σ2²1 . . . 0
. . .
0 0 . . . σ2²(t−1)
 .
Now we denote the vector of all measurements by
Y =
(
yijl
)
i=1,...,s, j=1,...,r, l=0,...,(t−1)
=
(
y
1
′
, y
2
′
, · · · , y
s
′)′
,
where y
i
=
(
yi10, . . . , yi1(t−1), yi20, . . . , yi2(t−1), . . . , yir0, . . . , yir(t−1)
)′
is the
vector of the measurements of length rt, stacked first by replicate and then
by dilution level for the ith sample. Also let G, ∆, and Ω denote the vectors
of length srt for the mean effects, the random effects for replicate, and
the within-group errors, respectively. These vectors are stacked by sample,
replicate and sample so that the first rt observations correspond to the first
sample, the first t observations correspond to the first replicate of the first
sample, and so on. Then we have
Y = G+∆+Ω,
and Υ = ∆+Ω follows the normal distribution with E(Υ) = 0 and cov(Υ) =
Is⊗
(
Vδ ⊗Jt+ Ir⊗V²
)
, where Jr = 1r1
′
r and 1r = (1, · · · , 1)
′
. The following
conditional (co)variances of the measurements given the mean effect, g, may
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help us to understand better the dependence structure,
var(yijl | g) = σ2δ + σ2²l ,
cov(yijl, yijl∗ | g) = σ2δ , l 6= l∗,
cov(yij·, yij∗· | g) = ρσ2δ , j 6= j∗,
cov(yi··, yi∗·· | g) = 0, i 6= i∗. (3.2)
In order for the variance-covariance matrix of Υ to be positive definite, we
need the following conditions:
σ2δ > 0, σ
2
²l
> 0, − 1
r − 1 < ρ < 1. (3.3)
3.3 Estimation Methods
To show Model (3.1) adds value to the analysis, we propose a method that
approximates the joint maximum likelihood estimate (this method, here-
after, will be referred to as the joint maximum likelihood estimation). As
preliminary studies, we evaluate how well the joint MLE works for estimat-
ing the variance components by using simulated data and real data. Besides
the joint MLE, another method, two-stage estimation, is considered but it
turns out that this method often fails to accurately estimate the variance
components.
3.3.1 Joint Maximum Likelihood Estimation
We consider the first method for estimating the parameters in Model (3.1).
Since it approximates the joint maximum likelihood estimate, we will refer
this method as the joint maximum likelihood estimation. In this method, we
estimate jointly all the parameters that maximize the likelihood function, in
an iterative way: estimating xi, Vδ and V² given β and estimating β given
xi, Vδ and V².
When estimating xi, Vδ and V² given β, we combine h samples, which
allows us to use the measurements of several samples for the estimation and
thus to attain more accurate and stable estimates than the estimates from
a single sample. However, if h is too large (e.g. h = s), the estimation
may suffer from a high-dimensional parameter space. On the other hand,
when estimating β given xi, Vδ and V², we use the measurements from all
samples. After that, to obtain more refined and stable estimates, we may
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use further estimation steps. The details are given below.
Step 1: Estimate xi, σ2δ , ρ, and σ
2
²l
given β.
(a) Choose a small value of h and combine h samples into one group,
resulting in s/h groups (or its integer part).
(b) For each group, find the estimates of xi, σ2δ , ρ and σ
2
²l
that mini-
mize the following function with the constraints of (3.3):
−lnL(xi, σ2δ , ρ, σ2²l | yijl, βˆ) ∝ h ln(|Q|)+ h∑
i=1
(
y
i
− gi
)′
Q−1
(
y
i
− gi
)
,
where i = 1, · · · , h, j = 1, · · · , r, l = 0, · · · , (t−1), Q = Vδ⊗Jt+
Ir⊗V², yi is the vector for the measurements of the ith sample as
defined in Section 3.2.2, and gi is the rt by 1 vector for the mean
effects of the ith sample with β being fixed as βˆ, obtained from
the single-step procedure of [10]. Hence, gi consists of r identical
vectors of length t, which is given by(
g
(
βˆ, xi
)
, g
(
βˆ, xi − 1
)
, · · · , g(βˆ, xi − (t− 1)))′ .
(c) Find the median of the s/h estimates for each of σ2δ , ρ and σ
2
²l
, and
construct the variance-covariance matrix based on those medians.
The variance-covariance matrix is Qˆ = Vδ ⊗ Jt + Ir ⊗ V².
Step 2: Estimate β given xi, σ2δ , ρ, and σ
2
²l
by finding the estimate that
minimizes the following function:
−lnL(β | yijl, xˆi, Qˆ) ∝ s∑
i=1
(
y
i
− gˆi
)′
(Qˆ)−1
(
y
i
− gˆi
)
,
where i = 1, · · · , s, j = 1, · · · , r, l = 0, · · · , (t − 1), xˆi and Qˆ are
the estimates obtained from Step 1, and gˆi is the vector for the mean
effects of the ith sample with xi being fixed as xˆi.
Step 3: Repeat Step 1 using the β estimate obtained from Step 2.
After this one-step iteration, we use one further estimation step to obtain
more refined and stable estimates.
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Step 4: Estimate σ2δ , ρ, and σ
2
²l
using a linear mixed effects model, and
estimate xi and β using the multi-step procedure of Chapter 2.
(a) Find the the maximum likelihood estimates for σ2δ , ρ, and σ
2
²l
,
in Vδ and V², using the following linear mixed effects model as an
approximate,
ηˆijl = δij + ²ijl,
where i = 1, · · · , s, j = 1, · · · , r, l = 0, · · · , (t − 1), ηˆijl are the
residuals obtained with the most updated estimates for β and xi,
and δij and ²ijl are the random effects of the dilution series and
the within-group errors, respectively, as defined in Model (3.1).
(b) Find the estimates for xi and β using the multi-step procedure
after a modification to implement the weighted least squares es-
timation method.
i. Find group-based estimates for xi and β that minimize the
following objective function:
k∑
i=1
(
y
i
− gi
)′
Q˜−1
(
y
i
− gi
)
,
where Q˜ is the variance-covariance matrix constructed with
the most updated estimates for the variance components, y
i
is the vector for the measurements of the ith sample, and gi
is the vector for the mean effects of the ith sample.
ii. Pool the group-based estimates for β using the same criteria
as in Section 2.2.2.
iii. Given β, estimate xi that minimizes the following objective
function: (
y
i
− g˜i
)′
Q˜−1
(
y
i
− g˜i
)
,
where i = 1, · · · , s, and g˜i is the vector for the mean effects
of the ith sample with β being fixed as the pooled estimate.
In our implementation, we use the R function optim for Steps 1 – 3 and
Step 4 (b), and lme for Step 4 (a). In Step 1, the starting value of xi is
obtained from the single-step procedure, and for the starting values for σ2δ ,
ρ, and σ2²l , we compute the sample moments of the first three (co)variances
in (3.2), and then find the corresponding sample moments of σ2δ , σ
2
²l
, and ρ.
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The joint maximum likelihood estimate of all the parameters could be ob-
tained at once by maximizing one log-likelihood function, but the proposed
one-step iteration reduces numerical challenges in optimization, because we
avoid working directly with a high-dimensional parameter space.
3.3.2 Two-Stage Estimation
We consider the second method for estimating the parameters in Model
(3.1). In this method, we first estimate xi and β under the i.i.d. error as-
sumption as in Chapter 2, and obtain the residuals. After that, we estimate
all parameters using the method described in Step 4 of the joint MLE. Un-
like the joint MLE, the variance components (Vδ and V²) are not estimated
jointly with xi and β in this method. By using simulated data, we will
show in Section 3.3.3 that this separate estimation often produces biased
estimates for the variance components. The details of the two-stage method
are as follows.
Step 1: Find the estimates for xi and β using the single-step least squares
method discussed in [10], and then obtain the residuals, ηˇijl.
Step 2: Estimate σ2δ , ρ, and σ
2
²l
using a linear mixed effects model, and
estimate xi and β using the multi-step procedure of Chapter 2.
(a) Find the the maximum likelihood estimates for σ2δ , ρ, and σ
2
²l
,
in Vδ and V², using the following linear mixed effects model as an
approximate,
ηˇijl = δij + ²ijl,
where i = 1, · · · , s, j = 1, · · · , r, l = 0, · · · , (t − 1), ηˇijl are the
residuals obtained by using the estimates for xi and β from the
previous step, and δij and ²ijl are the random effects of the di-
lution series and the within-group errors, respectively, as defined
in Model (3.1).
(b) Find the estimates for xi and β using the multi-step procedure
after a modification to implement the weighted least squares es-
timation method.
i. Find group-based estimates for xi and β that minimize the
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following objective function:
k∑
i=1
(
y
i
− gi
)′
Qˇ−1
(
y
i
− gi
)
,
where Qˇ is the variance-covariance matrix constructed by us-
ing the most updated estimates for the variance components.
ii. Pool the group-based estimates for β using the same criteria
as in Section 2.2.2.
iii. Given β, estimate xi that minimizes the following objective
function: (
y
i
− gˇi
)′
Qˇ−1
(
y
i
− gˇi
)
,
where i = 1, · · · , s, and gˇi is the vector for the mean effects
of the ith sample with β being fixed as the pooled estimate.
The main purpose of this method is that we hope to capture the real error
structure by using the residuals obtained under the i.i.d. working assump-
tion. However, it turns out that the residuals do not represent the true errors
very well in terms of correlation, as we will show later in Section 3.3.3. One
possible explanation is as follows. Suppose that three random variables, X1,
X2 and X3, are positively correlated. Yet, X1− X¯ and X2− X¯ are not nec-
essarily positively correlated. This can happen especially when the number
of X ′s is small. For example, let var(X1) = var(X2) = var(X3) = 1 and
cov(X1, X2) = cov(X1, X3) = cov(X2, X3) = % > 0. It follows that
cov(X1 − X¯, X2 − X¯) =
(2
3
,−1
3
,−1
3
)
cov(X1, X2)
(
− 1
3
,
2
3
,−1
3
)′
= −1
3
(1− %) ≤ 0.
In a similar way, even if two dilution series of a certain biological sample are
correlated, their residuals might not have been correlated, especially when
the number of replicates (= r) is small.
3.3.3 Studies with Simulated Data
In this section, we evaluate how well two methods work for estimating the
variance components in Model (3.1) using simulated data. We consider
mainly two scenarios:
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(i) when σ2δ is strictly positive (when the random effects exist), and
(ii) when σ2δ equals zero (when the random effects do not exist).
If there are no random effects, the measurements can be considered as in-
dependent. For each scenario, we assume either
(i) heteroscedastic measurement errors (the different diagonal elements in
V²) or
(ii) homoscedastic measurement errors (the common diagonal element in
V²).
If σ2δ = 0 and V² has the common diagonal element, then the measurements
are considered as i.i.d.We use the following values: s = 96, r = 3, t = 6, and
β = (10, 15, 1)
′
. We generate the concentration levels from the skew-normal
distribution with location, scale, and shape parameters (3,2,-3), whose den-
sity matches closely the empirical distribution of xi estimates from the real
data analyses of array pThr308AKT , array AKT , and array pmTor (see
Figure 2.3). For the joint MLE, we combine h = 12 samples when estimating
xi, Vδ and V². In the first scenario, we assume that
σ2δ = 1, ρ = 0.7, (σ
2
²0 , σ
2
²1 , σ
2
²2 , σ
2
²3 , σ
2
²4 , σ
2
²5)
′
= (0.40, 0.35, 0.30, 0.25, 0.20, 0.15)
′
.
The estimation results from two methods are given in Table 3.1. The two-
stage estimation gives very poor estimates overall. Especially the estimate
for σ2δ is too small and the estimate for ρ is even negative although the true
correlation coefficient is quite high at 0.7. On the other hand, the estimates
of the joint MLE are very close to the true values. In the second scenario,
we assume that
σ2δ = 1, ρ = 0.7, σ
2
²l
= 0.1, for l = 0, · · · , 5.
Again, the two-stage estimation gives very poor estimates, too small for σ2δ
and negative for ρ, while the joint MLE yields good estimation results. In
the third scenario, we assume that
σ2δ = 0, ρ = 0.7, (σ
2
²0 , σ
2
²1 , σ
2
²2 , σ
2
²3 , σ
2
²4 , σ
2
²5)
′
= (0.40, 0.35, 0.30, 0.25, 0.20, 0.15)
′
.
As shown in Table 3.1, the estimate for σ2δ is close to zero for both methods.
Because σ2δ = 0, two parameters, σ
2
δ and ρ, are not separately identified,
and thus the result for ρ is not meaningful. The estimates for σ2²l are quite
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Table 3.1: Estimation results for the variance components of two methods
based on simulated data.
True Value Joint MLE Two-Stage
Scenario 1 σ2δ 1.00 1.12 0.19
ρ 0.70 0.75 −0.26
σ2²0 0.40 0.33 0.61
σ2²1 0.35 0.39 0.52
σ2²2 0.30 0.26 0.36
σ2²3 0.25 0.23 0.32
σ2²4 0.20 0.23 0.38
σ2²5 0.15 0.11 0.54
Scenario 2 σ2δ 1.00 1.13 0.19
ρ 0.70 0.76 −0.33
σ2²l 0.10 0.10 0.30
Scenario 3 σ2δ 0.00 0.00 0.00
σ2²0 0.40 0.31 0.32
σ2²1 0.35 0.37 0.35
σ2²2 0.30 0.25 0.26
σ2²3 0.25 0.22 0.22
σ2²4 0.20 0.20 0.19
σ2²5 0.15 0.15 0.15
Scenario 4 σ2δ 0.00 0.00 0.00
σ2²l 0.10 0.10 0.09
accurate with both methods. Finally, in the fourth scenario, we assume that
σ2δ = 0, ρ = 0.7, σ
2
²l
= 0.1, for l = 0, · · · , 5.
Again, the estimate for σ2δ is close to zero for both methods. The result for
ρ is not meaningful due to an identifiability problem. The estimates for σ2²l
are reasonably good with both methods.
Using simulated data, we have considered four different scenarios regard-
ing the dependence structure of the errors. The joint MLE leads to ro-
bust estimation results for the parameters in the variance-covariance ma-
trix. However, the two-stage estimation gives very poor estimates when the
random effects are present.
Therefore, for more extensive simulation studies later in Section 3.4, we
employ the joint MLE for estimating the parameters in Model (3.1), whose
estimation results will be compared with those of an existing method without
accounting for correlation.
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3.3.4 Studies with Real Data
We apply the two methods to three different lysate arrays in order to see
whether we have similar findings to the results with simulated data.
The first array, the lysate array of the protein pThr308AKT , is mentioned
in Section 3.4.1. In this array, 96 (s = 96) samples are 2-fold serially diluted
six times (t = 6) and spotted on a slide in triplicate (r = 3). We use the
heteroscedastic error assumption and for the joint MLE, we combine h = 12
samples when estimating xi, Vδ and V². The estimation results for σ2δ , ρ and
σ2²l from the two methods are given in Table 3.2. The results of two methods
do not appear considerably different. The estimate for σ2δ is very small for
both methods, even considering the small scale of the measurements on this
array. More precise values of the estimates are 2.60e-04 for the two-stage
estimation and 3.95e-06 for the joint MLE. It seems that the random effects
for the dilution series are not strong in this array. Then the estimate for ρ
is not informative. Two methods give very similar estimates for σ2²l , which
supports our conclusion with simulated data that two methods give similar
results when the random effects are negligible.
However, the arrays of AKT and pmTor tell a different story. These
arrays have been used in Section 3.2.1 and in both arrays, 40 samples (s =
40) are diluted eight times (t = 8) by a factor of two and spotted on a slide
in duplicate (r = 2). For the Joint MLE, we combine h = 10 samples when
estimating xi, Vδ and V². As shown in Table 3.2, for these two arrays, the
random effects are not negligible and two methods lead to very different
estimation results. The estimates for σ2δ of the two-stage estimation are
much smaller than the estimates of the joint MLE. For instance, in the array
of AKT , the estimate from the two-stage estimation is 28 · 103, whereas the
estimate of the joint MLE is 1675 · 103. In addition, the estimates for ρ
from the two-stage estimation are negative, while the estimates from the
joint MLE are large for both arrays. For example, in the array of AKT , the
estimate from the two-stage estimation is −0.24, while the estimate from
the joint MLE is 0.87. The results support our conclusion with simulated
data that when the random effects exist, the two-stage estimation tends to
underestimate σ2δ and ρ. The scales for three arrays are very different due
to the use of different spot-quantification softwares.
The application to real data shows similar patterns to those obtained with
simulated data, and indicates that some lysate array data may have strong
random effects of the dilution series. It seems quite necessary, therefore, to
take into account the non-i.i.d. errors when analyzing the lysate array data.
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Table 3.2: Estimation results for the variance components of two methods
based on three lysate arrays.
Joint MLE Two-Stage
Array for pThr308AKT σ2δ 0.00 0.00
ρ 0.45 0.67
σ2²0 0.47 0.49
σ2²1 0.13 0.14
σ2²2 0.01 0.01
σ2²3 0.07 0.06
σ2²4 0.15 0.13
σ2²5 0.19 0.18
Array for AKT σ2δ 1675 · 103 28 · 103
ρ 0.87 −0.24
σ2²0 7 · 106 1 · 106
σ2²1 23 · 106 3 · 106
σ2²2 13 · 106 2 · 106
σ2²3 8 · 106 2 · 106
σ2²4 3 · 106 3 · 106
σ2²5 0.5 · 106 1 · 106
σ2²6 0.1 · 106 0.3 · 106
σ2²7 0.3 · 106 0.2 · 106
Array for pmTor σ2δ 305 · 103 0.22 · 103
ρ 0.75 −0.44
σ2²0 5 · 106 3 · 106
σ2²1 3 · 106 1 · 106
σ2²2 0.3 · 106 0.4 · 106
σ2²3 0.5 · 106 1 · 106
σ2²4 0.8 · 106 0.9 · 106
σ2²5 0.5 · 106 1 · 106
σ2²6 0.3 · 106 0.7 · 106
σ2²7 0.1 · 106 0.5 · 106
54
3.3.5 An Example with Joint MLE
The Joint MLE mainly consists of two parts: a one-step iteration procedure
and a refining procedure to attain better estimates. In this section, using a
simulated data set we will show that the one-step iteration (or even several
iterations) sometimes produces poor estimates, leaving room for improve-
ment with a refining procedure.
We generate data from Model (3.1) using the following values:
s = 96, r = 3, t = 6, β = (1, 1.5, 1)
′
, σ2δ = 0.1
2, ρ = 0.7,
(σ2²0 , σ
2
²1 , · · · , σ2²5)
′
= (0.12, 0.12, · · · , 0.12)′ .
The concentration levels are generated from the skew-normal distribution
with location, scale, and shape parameters (3,2,-3). We combine h = 24
samples when estimating xi, Vδ and V².
Figure 3.2 shows the estimation results after several iterations. The first
plot compares the relative concentration estimates, xˆi − xˆref , with the true
levels. The results after one, three, seven, and ten iterations are presented.
We see that the estimates are more deviated from the true levels after ten
iterations than after one iteration. The solid line is the 45-degree line. The
plot in the upper right corner shows the trend of Dtot with the number
of iterations. As in the previous chapter, Dtot is defined as the sum of
the absolute differences between the estimated relative concentration levels
and the true relative levels. Overall, the value of Dtot increases with the
number of iterations. The two plots in the bottom row show the trend of σ2δ
estimates and ρ estimates, with the number of iterations, respectively. The
dashed lines indicate the true values in both plots. The estimates are quite
far off from the true values after one-step iteration or after several iterations.
This example shows that repeated iterations between Steps 1 and 2 in the
joint MLE procedure do not necessarily lead to good results. That is why
we use Step 4 as a refining procedure.
3.4 Simulation Studies
Now we carry out several simulation studies to evaluate the overall perfor-
mance of the joint MLE (not only the estimation of the variance components
but also the estimation of xi and β), in comparison with the single-step least
squares procedure on all the samples used in [10]. We consider three different
cases of error structures and curve parameters.
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Figure 3.2: The upper left corner corresponds to the comparison of the
relative concentration estimates with the true relative levels. The upper
right corner corresponds to Dtot values along with the number of
iterations. Two plots in the bottom row correspond to σ2δ estimates and ρ
estimates, with the number of iterations, respectively, and the dashed lines
indicate the true values in both plots.
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3.4.1 Implementation Details and Assessment Criteria
When generating simulation data sets, we try to imitate real data, and
thus we use as references the results of the real data analysis that has been
performed in the previous chapter and in Section 3.3.4. Throughout the
studies, we assume that the number of samples is 96 (s = 96), the number
of replicates is 3 (r = 3), and the number of dilution levels is either 6 or
8 (t = 6 or 8). We generate xi from the skew-normal distribution with
location, scale, and shape parameters (3,2,-3). We use the identical set of
xi (i = 1, · · · , s) for 100 simulation data sets throughout the studies. For
the joint MLE, we combine h = 12 samples when estimating xi, Vδ and V².
For each simulation data set, we compute the same performance measure,
Dtot, as in the previous chapter. The middle sample, in terms of the true
concentration level, is used as the reference again. The definition of Dtot is
as follows:
Dtot =
s∑
i=1
|D˜i −Di|,
where D˜i = x˜i − x˜ref , Di = xi − xref , x˜i and x˜ref are the estimates
for the concentration levels of the ith sample and of the reference sample,
respectively, and xi and xref are their true values. The smaller Dtot is, the
more desirable the result is.
In addition, the same Winsorization rule as in Section 2.4.1 is applied.
3.4.2 Simulation Case 1
We consider a case where the random effects of the dilution series are strong
and the errors are heteroscedastic. We assume that
σ2δ = 1, ρ = 0.7, (σ
2
²0 , σ
2
²1 , σ
2
²2 , σ
2
²3 , σ
2
²4 , σ
2
²5)
′
= (0.40, 0.35, 0.30, 0.25, 0.20, 0.15)
′
.
In addition, we use β = (10, 15, 1)
′
. Figure 3.3 shows the distributions of
Dtot, based on 100 simulation data sets. The first plot corresponds to the
joint MLE and the second plot corresponds to the single-step procedure used
in [10]. Evidently, in this case the joint MLE leads to smaller Dtot than the
single-step procedure. It indicates that when the random effects exist, the
method that ignores these effects may yield poor estimation results for xi.
The summary statistics of Dtot for two methods, are given in Table 3.3.
Table 3.3 presents the estimation results for the curve parameters, in-
cluding the summary statistics and the mean squared error based on 100
57
estimates for each of the curve parameters. For each of the parameters,
β1, β2, and β3, the joint MLE produces much smaller mean squared error
than the single-step procedure.
1) Joint MLE 2) Tabus
20
40
60
80
D
_t
ot
Figure 3.3: Box-and-Whisker plots of the distribution of Dtot in simulation
Case 1.
For further exploration, we examine two individual trials. Two plots in
the upper panel of Figure 3.4 are based on the data set, for which the
joint MLE shows the largest Dtot value, 27.27 (Dtot value of the single-step
procedure in this trial is 32.33). Two plots in the lower panel correspond
to the data set, for which the single-step procedure shows the largest Dtot
value, 89.34 (Dtot value of the joint MLE in this trial is 8.45). The plots in
the first column present the true curve and the data points, and the plots
in the second column compare two fitted curves of two methods with the
true curve for each trial. The fitted curves have been shifted horizontally
so that the x(-axis) value at the inflection point is zero, which is reasonable
because we are more interested in the relative value of the concentration
levels. In both trials, the fitted curve of the single-step procedure is slightly
off the true curve, while the joint MLE produces a good curve fit even for
the worst data set. It seems that the single-step procedure is more likely to
fail to accurately estimate the curve in the tails than the joint MLE, which
will surely affect the estimation for xi.
With the joint MLE, we can estimate the variance components. The
estimation results based on 100 data sets are given in Table 3.4. When
58
Table 3.3: Summary statistics of Dtot and the curve parameter estimates
in simulation Case 1.
True Value Joint MLE Tabus
Dtot Min. 6.17 22.20
Median 9.30 34.41
Mean 10.91 38.09
Max. 27.27 89.34
β1 Min. 10.00 9.80 9.37
Median 9.99 9.70
Mean 10.01 9.72
Max. 10.37 10.14
MSE 0.01 0.10
β2 Min. 15.00 14.60 15.02
Median 14.87 15.95
Mean 14.88 15.94
Max. 15.27 16.73
MSE 0.04 1.02
β3 Min. 1.00 0.96 0.83
Median 1.00 0.90
Mean 0.99 0.90
Max. 1.03 0.99
MSE 0.00 0.01
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Figure 3.4: True curve versus fitted curves of two methods in simulation
Case 1: two plots in the upper panel correspond to the worst trial for the
joint MLE, and two plots in the lower panel correspond to the worst trial
for the single-step procedure. The plots in the first column present the
true curve and the data points, and the plots in the second column
compare two fitted curves of two methods with the true curve.
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compared to the true values, the joint MLE works well for estimating the
variance components in Model (3.1).
In simulation Case 1, the random effects of the dilution series are strong.
We have found that the joint MLE leads to much more accurate estimates
for both xi and β than the single-step procedure used in [10]. It indicates
that when the random effects are present, the method that ignores these
effects can yield poor estimation results.
3.4.3 Simulation Case 2
We consider a case where the random effects of the dilution series are not
present and the errors are homoscedastic, that is, the errors are i.i.d. It
turns out that the proposed joint MLE gives comparable estimation results
to the single-step procedure, which is designed under the i.i.d. model. We
assume that
σ2δ = 0, ρ = 0.7, σ
2
²l
= 50, l = 0, · · · , 5.
In addition, we assume that β = (100, 250, 0.7)
′
. The choice for the values
of the curve parameters takes the cue from the real data analysis performed
in Section 3.3.4. Particularly, in pmTor array, we have noticed that the
median of σˆ²l is roughly 5% of βˆ2 − βˆ1.
The distributions of Dtot, based on 100 data sets, are given in Figure
3.5. Two methods produce very similar results regarding Dtot. However, as
shown in Table 3.5, the joint MLE gives much smaller mean squared error
for the curve parameters than the single-step procedure.
The variance component estimates of the joint MLE, based on 100 trials,
are given in Table 3.6. In terms of the medians or means, the estimates for
σ2δ and σ
2
²l
are reasonably accurate. Due to an identifiability problem, the
estimate for ρ is not meaningful in this case.
In simulation Case 2, we assume that the measurement errors are i.i.d.
The joint MLE and the single-step procedure give very similar estimation
results for xi. If we take it into account that the single-step procedure of [10]
is designed for the i.i.d. case, the joint MLE has a robust performance.
3.4.4 Simulation Case 3
To mimic the data we saw from the protein, pmTor analyzed in Section
3.3.4, we use the following values:
β = (11187, 26007, 0.7)
′
, σ2δ = 305054, ρ = 0.75,
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Table 3.4: Estimation results for the variance components in simulation
Case 1.
True Value Joint MLE
σ2δ Min. 1.00 0.66
Median 0.96
Mean 0.96
Max. 1.39
ρ Min. 0.70 0.51
Median 0.67
Mean 0.67
Max. 0.81
σ2²0 Min. 0.40 0.26
Median 0.37
Mean 0.37
Max. 0.50
σ2²1 Min. 0.35 0.26
Median 0.33
Mean 0.33
Max. 0.44
σ2²2 Min. 0.30 0.23
Median 0.29
Mean 0.29
Max. 0.37
σ2²3 Min. 0.25 0.18
Median 0.24
Mean 0.24
Max. 0.30
σ2²4 Min. 0.20 0.15
Median 0.20
Mean 0.20
Max. 0.25
σ2²5 Min. 0.15 0.09
Median 0.13
Mean 0.13
Max. 0.18
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Figure 3.5: Box-and-Whisker plots of the distribution of Dtot in simulation
Case 2.
Table 3.5: Summary statistics of Dtot and the curve parameter estimates
in simulation Case 2.
True Value Joint MLE Tabus
Dtot Min. 3.34 3.32
Median 5.10 5.14
Mean 5.74 5.70
Max. 12.68 12.62
β1 Min. 100.00 98.88 68.73
Median 100.50 99.97
Mean 100.50 99.40
Max. 102.80 102.00
MSE 0.86 18.40
β2 Min. 250.00 241.60 245.20
Median 247.90 250.50
Mean 247.60 253.50
Max. 253.60 416.80
MSE 11.98 533.76
β3 Min. 0.70 0.68 0.40
Median 0.70 0.70
Mean 0.70 0.69
Max. 0.73 0.72
MSE 0.00 0.00
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Table 3.6: Estimation results for the variance components in simulation
Case 2.
True Value Joint MLE
σ2δ Min. 0.00 0.00
Median 0.27
Mean 0.42
Max. 2.54
σ2²l Min. 50.00 42.49
Median 46.98
Mean 47.34
Max. 78.96
(σ2²0 , σ
2
²1 , σ
2
²2 , σ
2
²3 , σ
2
²4 , σ
2
²5 , σ
2
²6 , σ
2
²7)
′
= (4542884, 2883969, 342657, 471029, 818083, 506195, 321632, 49902)
′
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Figure 3.6: Box-and-Whisker plots of the distribution of Dtot in simulation
Case 3.
Figure 3.6 shows the distributions ofDtot, based on 100 data sets. Overall,
the joint MLE leads to smaller Dtot than the single-step procedure. Again,
the results imply that we should use the method that incorporates the ran-
dom effects when the effects exist. Besides, Table 3.7 shows that the joint
MLE leads to more accurate curve parameter estimation as well.
We explore an individual trial in which both the joint MLE and the single-
64
Table 3.7: Summary statistics of Dtot and the curve parameter estimates
in simulation Case 3.
True Value Joint MLE Tabus
Dtot Min. 5.91 12.92
Median 8.83 21.26
Mean 9.52 22.26
Max. 19.11 41.27
β1 Min. 112 · 102 110 · 102 109 · 102
Median 112 · 102 112 · 102
Mean 112 · 102 112 · 102
Max. 113 · 102 114 · 102
MSE 36 · 102 89 · 102
β2 Min. 260 · 102 247 · 102 254 · 102
Median 257 · 102 263 · 102
Mean 257 · 102 263 · 102
Max. 266 · 102 277 · 102
MSE 2341 · 102 3017 · 102
β3 Min. 0.70 0.67 0.66
Median 0.70 0.69
Mean 0.70 0.69
Max. 0.73 0.72
MSE 0.00 0.00
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step procedure show the worst performance in terms of Dtot: the joint MLE
gives 19.11 and the single-step procedure gives 41.27. Figure 3.7 presents
the true curve and the fitted curves of two methods for this worst trial.
The single-step procedure fails to accurately estimate the upper part of the
curve. On the other hand, the joint MLE gives a reasonably good curve fit
even in this trial.
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Figure 3.7: True curve versus fitted curves of two methods in simulation
Case 3: these plots are based on the worst simulation trial for both
methods in terms of Dtot. The left plot presents the true curve and the
data points, and the right plot compares the fitted curves of two methods
with the true curve.
The variance component estimates for the joint MLE are given in Table
3.8. In terms of the medians or means, the estimates appear to be reasonably
acceptable, although they are not as precise as in the previous two cases.
The variation of the 100 estimates is quite large.
In simulation Case 3, we assume that the random effects of the dilution
series are strong and the error variances are large. The joint MLE still
leads to more accurate estimates (both for xi and β) than the single-step
procedure.
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Table 3.8: Estimation results for the variance components in simulation
Case 3.
True Value Joint MLE
σ2δ Min. 0.3 · 106 0.1 · 106
Median 0.3 · 106
Mean 0.3 · 106
Max. 0.6 · 106
ρ Min. 0.75 −0.26
Median 0.65
Mean 0.58
Max. 0.92
σ2²0 Min. 5 · 106 2 · 106
Median 4 · 106
Mean 4 · 106
Max. 5 · 106
σ2²1 Min. 3 · 106 2 · 106
Median 3 · 106
Mean 3 · 106
Max. 4 · 106
σ2²2 Min. 0.3 · 106 0.2 · 106
Median 0.3 · 106
Mean 0.3 · 106
Max. 0.5 · 106
σ2²3 Min. 0.5 · 106 0.3 · 106
Median 0.5 · 106
Mean 0.5 · 106
Max. 0.7 · 106
σ2²4 Min. 0.8 · 106 0.6 · 106
Median 0.8 · 106
Mean 0.8 · 106
Max. 1.4 · 106
σ2²5 Min. 0.5 · 106 0.4 · 106
Median 0.5 · 106
Mean 0.5 · 106
Max. 0.8 · 106
σ2²6 Min. 0.3 · 106 0.2 · 106
Median 0.3 · 106
Mean 0.3 · 106
Max. 0.6 · 106
σ2²7 Min. 0.1 · 106 0.0 · 106
Median 0.1 · 106
Mean 0.1 · 106
Max. 0.3 · 106
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3.4.5 Confidence Intervals
Finally, we compute the confidence intervals for the relative concentration
levels, and investigate coverage probability performances of the joint MLE
and the single-step procedure. When the errors are non-i.i.d., the ordinary
least squares estimation used for the single-step procedure is well known to
produce a biased variance estimate, resulting in incorrect confidence inter-
vals.
In the previous chapter, we have shown that the convergence rate of the
curve parameter estimate is faster than that of the concentration estimate:
the convergence rate of the former is Op
(
(srt)−1/2
)
, while the convergence
rate of the latter is Op
(
(rt)−1/2
)
. We can expect that the convergence rate
of the variance-covariance matrix, cov(Υ) = Is⊗
(
Vδ⊗Jt+Ir⊗V²
)
, in Model
(3.1) will be also faster than that of the concentration level. Therefore, the
estimate of xi for the joint MLE will be as efficient as in a problem with
known curve parameters and known variance-covariance matrix. Then the
variance of x˜i takes the following form:
var(x˜i) =
[ (∂gi
∂xi
)′
Q−1
(∂gi
∂xi
) ]−1
,
where gi is the rt by 1 vector for the mean effects of the ith sample and
Q = Vδ⊗Jt+Ir⊗V². Using the joint MLE, we can construct a 100(1−α)%
asymptotic confidence interval for xi − xref as follows:
CI1 = (x˜i − x˜ref )± zα/2
(
v̂ar(x˜i) + v̂ar(x˜ref )
)1/2
,
where v̂ar(x˜i) and v̂ar(x˜ref ) are the estimates for var(x˜i) and var(x˜ref ),
which are obtained by replacing the true values with the corresponding
estimates of the joint MLE.
[10] did not provide a variance estimate, but we can use the asymptotic
result of Theorem 1 in the previous chapter to compute the variance, because
we expect Theorem 1 to hold for the single-step estimates. Then the variance
of xˆi is given by
var(xˆi) =
σ2
r
[ t−1∑
l=0
β2
2β3
2e−2β3(xi−l)(
1 + e−β3(xi−l)
)4 ]−1,
which takes the same form as
var(xˆi) = σ2
[ (∂gi
∂xi
)′ (∂gi
∂xi
) ]−1
.
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Using the single-step procedure, we can construct a 100(1−α)% asymptotic
confidence interval for xi − xref as follows:
CI2 = (xˆi − xˆref )± zα/2
(
v̂ar(xˆi) + v̂ar(xˆref )
)1/2
,
where v̂ar(xˆi) and v̂ar(xˆref ) are the estimates for var(xˆi) and var(xˆref ),
which are obtained by replacing the true values with the corresponding
estimates of the single-step procedure. We estimate σ2 by
σˆ2 =
∑
ijl
(
yijl − g(βˆ, xˆi − l)
) /
(srt− s− 3),
where g(β, xi − l) = β1 + β21+e−β3(xi−l) .
For the simulation setting of Case 1, we compute 90% confidence intervals.
We use 100 data sets and for each data set we compute 95 confidence inter-
vals on pairwise difference (xi − xref , i = 1, 2, ..., 96, i 6= ref). Again, as a
reference, we use the sample whose true concentration level is the median of
96 xi’s. The coverage probability is defined as the proportion of the intervals
that contain the true value among 100× 95 intervals. In addition, we define
the interval length for each of 95 confidence intervals on pairwise difference,
as the average length of the corresponding 100 confidence intervals, which
makes sense because we use the identical xi’s for all 100 data sets. It turns
out that the single-step procedure has a very low coverage probability, 0.32,
due to the severe bias in the estimation for xi − xref , as already shown in
Figure 3.3, and also generally short intervals, as shown in Figure 3.8. On
the other hand, the coverage probability for the joint MLE is 0.90, which is
equal to the nominal level. Overall, the joint MLE results in wider confi-
dence intervals than the single-step procedure as shown in Figure 3.8. The
average interval length of all 100 × 95 intervals is 0.44 for the joint MLE,
and 0.39 for the single-step procedure. Three samples whose xi estimates
are in the tails have been excluded from Figure 3.8 for both methods.
Next, we use the simulation setting of Case 2, and compute 90% confi-
dence intervals. In this case, the measurement errors are i.i.d. The coverage
probabilities of the joint MLE and the single-step procedure are 0.89 and
0.90, respectively. In the i.i.d. case, both methods have the coverage proba-
bilities that are very close to the nominal level. However, as shown in Figure
3.9, the joint MLE produces slightly shorter confidence intervals than the
single-step procedure. Again, the three samples that have xi estimates in
the tails are not included in Figure 3.9. The average interval lengths are
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Figure 3.8: Confidence interval lengths for xi − xref in simulation Case 1.
Table 3.9: Coverage probabilities (the nominal level is 0.90) and average
confidence interval lengths.
Joint MLE Tabus
simulation Case 1 Coverage Prob. 0.90 0.32
Average Interval Length 0.44 0.39
Median Interval Length 0.44 0.37
simulation Case 2 Coverage Prob. 0.89 0.90
Average Interval Length 0.23 0.24
Median Interval Length 0.23 0.24
simulation Case 3 Coverage Prob. 0.88 0.56
Average Interval Length 0.36 0.38
Median Interval Length 0.34 0.36
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0.23 for the joint MLE, and 0.24 for the single-step procedure, as presented
in Table 3.9.
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Figure 3.9: Confidence interval lengths for xi − xref in simulation Case 2.
Based on the simulation setting of Case 3, we compute 90% confidence
intervals. The coverage probabilities of the joint MLE and the single-step
procedure are 0.88 and 0.56, respectively. For the joint MLE, the coverage
probability is slightly below the nominal level, but still considered accept-
able. For the single-step procedure, the coverage probability is far below
the nominal level. Figure 3.10 shows the confidence interval lengths of two
methods. The three samples whose xi estimates are in the tails are excluded
from this figure. The average lengths are 0.36 for the joint MLE, and 0.38
for the single-step procedure.
In this section, we investigate the joint MLE and the single-step procedure
in terms of the coverage probability and the length of confidence intervals in
three different simulation settings. The joint MLE has the coverage proba-
bility that is very close to the nominal level in all three cases. However, the
single-step procedure has a very low coverage probability in the cases with
non-i.i.d. errors and strong random effects of the dilution series.
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Figure 3.10: Confidence interval lengths for xi − xref in simulation Case 3.
3.4.6 Discussion and Future Work
A model that takes into account possible non-i.i.d. error structures appears
very necessary for analyzing the lysate array data, because the examination
of real data warns us that the i.i.d. assumption may be not reasonable in
reality. In this chapter, we introduce a new nonlinear mixed effects model
that allows for the dependence structure of the errors. Based on the new
model, we propose a method to approximate the joint maximum likelihood
estimator of all the parameters. Using simulation studies on various error
structures, we show that the proposed method leads to more accurate es-
timates for both the protein concentration levels and the curve parameters
than the single-step least squares procedure of [10], when strong random
effects of the dilution series are present. More importantly, the joint MLE
gives much better confidence intervals under various simulation settings,
whereas the procedure based on the i.i.d. error assumption often leads to
low coverage probabilities.
The dependence structure in our new model makes the likelihood function
more complicated. Also the likelihood involves a high-dimensional param-
eter space due to the nature of the lysate array data. We considered a
method to approximate the joint maximum likelihood estimator of all the
parameters, including the variance components, and showed that the results
are promising. As an alternative, in future work, we will employ two other
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methods that may improve computational efficiency and stability. The first
is the EM algorithm and the second is a Bayesian approach with MCMC.
In addition, based on the new model we will extend the multi-step proce-
dure proposed in the previous chapter. We estimate the parameters on the
group basis, and pool the group-based estimates for the curve parameters
and variance components using an appropriate weight matrix. Based on
these pooled estimates, we finally estimate the concentration levels. In do-
ing this, we avoid working with parameters of increasing dimensions, which
makes large sample inferences easy and helps the numerical computation
stable.
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APPENDIX A
We give the explicit expressions of Bvw and Mvw, 1 ≤ v, w ≤ (k + 3),
shown in Section 2.2.3 in Chapter 2. Let ηi = e−β
q
3(x
q
i−l), ηu = e−β
q
3(x
q
u−l)
and
∑
i,l =
∑k
i=1
∑t−1
l=0 . For u = 1, 2, ..., k, a = 4, 5, ..., (k + 2) and
b = (a+ 1), (a+ 2), ..., (k + 3), we have
B11 = tk, B12 =
∑
i,l
1
1 + ηi
, B13 =
∑
i,l
βq2(x
q
i − l)ηi(
1 + ηi
)2 , B1(u+3) = t−1∑
l=0
βq2β
q
3ηu(
1 + ηu
)2 ,
B22 =
∑
i,l
1(
1 + ηi
)2 , B23 =∑
i,l
βq2(x
q
i − l)ηi(
1 + ηi
)3 , B2(u+3) = t−1∑
l=0
βq2β
q
3ηu(
1 + ηu
)3 ,
B33 =
∑
i,l
(βq2)
2(xqi − l)2η2u(
1 + ηu
)4 , B3(u+3) = t−1∑
l=0
(βq2)
2βq3(x
q
u − l)η2i(
1 + ηu
)4 ,
B(u+3)(u+3) =
t−1∑
l=0
(βq2)
2(βq3)
2η2u(
1 + ηu
)4 , Bab = 0, Bvw = Bwv.
In addition to the common variance assumption of the errors, we also assume
that the measurements are independent across different biological samples
or different replicates, but dependent within the same replicate for the same
biological sample having the correlation coefficient ρ, that is, var(²ijl) = σ2,
cov(²ijl, ²i∗jl) = 0, cov(²ijl, ²ij∗l) = 0, and cov(²ijl, ²ijl∗) = ρσ2, i 6= i∗, j 6=
j∗,
l 6= l∗. Let η∗i = e−β
q
3(x
q
i−l∗),
∑
i,l,l∗ =
∑k
i=1
∑t−1
l=0
∑t−1
l∗=l+1, and
∑
l,l∗ =∑t−1
l=0
∑t−1
l∗=l+1 . Then, for u = 1, 2, ..., k, a = 4, 5, ..., (k + 2) and b = (a +
1), (a+ 2), ..., (k + 3), we have
M11 = tk + t(t− 1)kρ, M12 =
∑
i,l
1
1 + ηi
+ (t− 1)ρ
∑
i,l
1
1 + ηi
,
M13 =
∑
i,l
βq2(x
q
i − l)ηi(
1 + ηi
)2 + (t− 1)ρ∑
i,l
βq2(x
q
i − l)ηi(
1 + ηi
)2 ,
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M1(u+3) =
t−1∑
l=0
βq2β
q
3ηu(
1 + ηu
)2 + (t− 1)ρ t−1∑
l=0
βq2β
q
3ηu(
1 + ηu
)2 ,
M22 =
∑
i,l
1(
1 + ηi
)2 + 2 ρ∑
i,l,l∗
1(
1 + ηi
)(
1 + η∗i
) ,
M23 =
∑
i,l
βq2(x
q
i − l)ηi(
1 + ηi
)3 + 2 ρ∑
i,l,l∗
βq2(x
q
i − l)ηi(
1 + ηi
)2(1 + η∗i ) ,
M2(u+3) =
t−1∑
l=0
βq2β
q
3ηu(
1 + ηu
)3 + 2 ρ∑
l,l∗
βq2β
q
3ηu(
1 + ηu
)2(1 + η∗u) ,
M33 =
∑
i,l
(βq2)
2(xqi − l)2η2i(
1 + ηi
)4 + 2 ρ∑
i,l,l∗
(βq2)
2(xqi − l)(xqi − l∗)ηiη∗i(
1 + ηi
)2(1 + η∗i )2 ,
M3(u+3) =
t−1∑
l=0
(βq2)
2βq3(x
q
u − l)η2u(
1 + ηu
)4 + 2 ρ∑
l,l∗
(βq2)
2βq3(x
q
u − l)ηuη∗u(
1 + ηu
)2(1 + η∗u)2 ,
M(u+3)(u+3) =
t−1∑
l=0
(βq2)
2(βq3)
2η2u(
1 + ηu
)4 +2 ρ∑
l,l∗
(βq2)
2(βq3)
2ηuη
∗
u(
1 + ηu
)2(1 + η∗u)2 ,Mab = 0,Mvw =Mwv.
In the simulation studies in 2.4, we assume independence of the measure-
ments within replicate and then the terms involved with ρ are zero.
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APPENDIX B
Now we provide the proof of Lemma 1 when we use the trace minimiza-
tion procedure in Step 3 of the proposed algorithm. Lemma 1 also holds
for component-wise minimization, which can be shown in a similar way.
Suppose that the following conditions are satisfied:
(A1) 1ns/k
∑s/k
q=1
∑r
j=1
∑t−1
l=0 Σ
q
jl → Σ as n→∞ and s→∞,
(A2)
1
(ns/k)3/2
s/k∑
q=1
r∑
j=1
t−1∑
l=0
E||Sqjl||3 → 0 as n→∞ and s→∞,
(A3) (s/k) ≤ nA for some A,
where Σqjl,Σ, and S
q
jl are defined in the proof.
Proof of Lemma 1:
In the paper we show that
βˆ
(c)
=
s/k∑
q=1
V qβˆ
q
= β
o
+
1
n
s/k∑
q=1
r∑
j=1
t−1∑
l=0
V q T ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o)
+
s/k∑
q=1
V q T Rqn,
where T is a 3× (3 + k) matrix defined in (5) of the paper and
ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o) =
(
− 1
n
r∑
j=1
t−1∑
l=0
ψ˙(yq1jl, ..., y
q
kjl, θ
q
o)
)−1
ψ(yq1jl, ..., y
q
kjl, θ
q
o).
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It follows
√
ns/k (βˆ
(c) − β
o
) =
1√
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
P q T ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o)
+
√
ns/k
s/k∑
q=1
V q T Rqn,
where P q = ( 1s/k
∑s/k
q=1Ω
−1
q )
−1 Ω−1q . Define a new random vector, S
q
jl =
P q T ϕIF (y
q
1jl, ..., y
q
kjl, θ
q
o). Denote Σ
q
jl = var(S
q
jl).
Suppose that we have:
(A2
′
) For all ² > 0,
1
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
∫
||s||>²
√
ns/k
||s||2 dFi(s) → 0 as n→∞ and s→∞.
By [21], under conditions (A1) and (A2
′
), we can apply the Central Limit
Theorem for independent non-identically distributed random vectors and
thus
1√
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
Sqjl
d→ N(0, Σ) as n→∞ and s→∞. (B.1)
It is clear that (A2
′
) holds if we have (A2), because
1
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
∫
||s||>²
√
ns/k
||s||2 dFi(s)
=
1
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
E
(
||Sqjl||2 I
(||Sqjl|| ≥ ²√ns/k))
≤
s/k∑
q=1
r∑
j=1
t−1∑
l=0
E
( ||Sqjl||2
ns/k
||Sqjl||
²
√
ns/k
)
≤ 1
²
∑s/k
q=1
∑r
j=1
∑t−1
l=0 E||Sqjl||3
(ns/k)3/2
.
By [11], under (A3), ||Rqn|| is uniformly bounded in q such that
max
q
||Rqn|| = Op
((
log(s/k)
)2
n
)
,
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and
√
ns/k
s/k∑
q=1
V q T Rqn
p→ 0 as n→∞ and s→∞. (B.2)
Therefore, by Slutsky’s Theorem,
||βˆ(c) − β
o
|| = Op
(
(ns)−1/2
)
as n→∞ and s→∞.
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APPENDIX C
Now we prove Theorem 1 when we use the trace minimization procedure in
Step 3 of the proposed algorithm. Theorem 1 also holds for component-wise
minimization. Suppose that the following conditions are satisfied:
(B1) ϕIC(βˆ
(c)
) has continuous first and second derivatives in an open neigh-
borhood of β
o
.
Proof of Theorem 1:
We use the same definition of ϕIC(yijl, βˆ
(c)
, xio) as in the paper,
ϕIC(yijl, βˆ
(c)
, xio) =
(
− 1
n
r∑
j=1
t−1∑
l=0
φ˙(yijl, βˆ
(c)
, xio)
)−1
φ(yijl, βˆ
(c)
, xio).
Denote the first and second derivatives of ϕIC evaluated at βˆ
(c)
= β by
(ϕIC)
(1)
β and (ϕIC)
(2)
β , respectively. Then the multivariate Taylor expan-
sion ( [22] and [23]) of ϕIC around βo yields
√
n(x˜i−xio) = 1√
n
r∑
j=1
t−1∑
l=0
[
ϕIC(yijl, βo, xio)+[(ϕIC)
(1)
β
o
]
′(
βˆ
(c)−β
o
)+op
(||βˆ(c)−β
o
||)]+op(1).
It follows that
√
n (x˜i − xio) = 1√
n
r∑
j=1
t−1∑
l=0
ϕIC(yijl, βo, xio)
+
1√
n
r∑
j=1
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′ 1
n
s/k∑
q=1
r∑
j=1
t−1∑
l=0
V q T ϕIF (y
q
1jl, ... , y
q
kjl, θ
q
o)
+
1√
n
r∑
j=1
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′
s/k∑
q=1
V q T Rqn
+
1√
n
r∑
j=1
t−1∑
l=0
op
(||βˆ(c) − β
o
||)
+ op(1). (C.1)
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Let us now investigate the asymptotic behavior of each term on the right
side of (C.1). The first term can be rewritten as follows and by the Central
Limit Theorem it has an asymptotic normal distribution:
1√
n
r∑
j=1
t−1∑
l=0
(
− 1
n
r∑
j=1
t−1∑
l=0
φ˙(yijl, βˆo, xio)
)−1
φ(yijl, βˆo, xio)
d→ N
(
0, s2n
)
as n→∞,
where
s2n = tσ
2
[ t−1∑
l=0
(β2o)2(β3o)2e−2β3o(xio−l)(
1 + e−β3o(xio−l)
)4 ]−1.
The second term of (C.1) is
1√
s/k
1
n
r∑
j=1
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′ 1√
ns/k
s/k∑
q=1
r∑
j=1
t−1∑
l=0
Sqjl.
By the Weak Law of Large Numbers, it follows that
1
n
r∑
j=1
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′ p→ E
[
1
t
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′
]
as n→∞. (C.2)
By (B.1), the second term goes to zero as n → ∞ and s → ∞. The third
term of (C.1) is
1√
s/k
1
n
r∑
j=1
t−1∑
l=0
[(ϕIC)
(1)
β
o
]
′ √
ns/k
s/k∑
q=1
V q T Rqn,
and it goes to zero as n → ∞ and s → ∞ by (B.2) and (C.2). The fourth
term of (C.1) also converges to zero as n→∞ and s→∞ by the result of
Lemma 1. Therefore,
√
n (x˜i − xio) d→ N
(
0, s2n
)
as n→∞ and s→∞,
where s2n = tσ
2
[∑t−1
l=0
(β2o)2(β3o)2e−2β3o(xio−l)(
1+e−β3o(xio−l)
)4 ]−1.
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